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Summary            
 
Lumbar radicular pain constitutes only 5%-10% of low back pain conditions, but it accounts 
for 33% of the sick leave and 47% of the disability benefits due to back pain in Norway. 
Previous data show that the recovery from lumbar radicular pain may be influenced by 
physical, psychosocial, surgery-related and clinical factors. In addition, genetic factors can 
influence on the development of disc degeneration and the recovery after symptomatic disc 
herniation. 
 
The fact that inflammation contributes to the pathogenesis of disc herniation and radicular 
pain is now well established. The inflammatory response, initiated from the annulus fibrosus 
in case of disc herniation, may lead to increased levels of pro-inflammatory interleukins 
(ILs) close to nerve roots. This inflammatory process could also promote Modic changes. 
 
In this thesis, the role of such cytokines and genetic factors in recovery from lumbar radicular 
pain was addressed. The present data demonstrated a significant association between the 
inflammatory serum cytokine IL-6 and functional recovery from symptomatic disc 
herniation. Moreover, the genotype IL-1α C>T rs1800587 increased the risk of persistent 
pain 1-year after disc herniation. Regarding the radiological factors, we showed that type I 
Modic changes influences the short-term clinical outcome in patients with low back pain and 
radicular pain. A sex dependent effect of the opioid receptor mu 1 (OPRM1 A118G) 
rs1799971 genotype on recovery after disc herniation was also identified. 
 
It is concluded that inflammatory, radiological and genetic factors may be important for the 
recovery after lumbar disc herniation. 
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Norsk sammendrag (Summary in Norwegian)      
 
Radikulær utstrålende smerte på bakgrunn av skiveherniering representerer kun 5%-10% av 
alle korsryggsmerter, men står for 33% av sykefraværet og 47% av uføretrygden relatert til 
slike ryggplager i Norge. Tidligere studier har vist at fysiske, psykososiale, kirurgirelaterte 
og kliniske faktorer påvirker sykdomsforløp ved lumbal skiveherniering.  I tillegg kan 
genetiske faktorer ha betydning for utvikling av skivedegenerasjon og sykdomsforløp etter 
skiveherniering. 
 
Patogenesen ved prolapsbetinget radikulær utstrålende smerte omfatter både inflammatorisk 
og mekanisk nerverotspåvirkning. Inflammasjon igangsettes av annulus ruptur som ofte fører 
til skiveherniering med frisettelse av en rekke proinflammatoriske stoffer bl.a. interleukiner 
(ILer) som påvirker nerverøttene.  Det  er  også  vist  at  denne  proinflammatoriske  
prosessen fremmer dannelse av Modic forandringer. 
 
I dette arbeidet er betydning av inflammatoriske og genetiske faktorer for sykdomsforløp ved 
symptomgivende skiveherniering studert. Våre resultater viste en signifikant assosiasjon 
mellom det inflammatoriske serum cytokinet IL-6 og gjenvinning av funksjon. Videre, ble 
det vist at genotypen IL-1α C>T rs1800587 økte risikoen for vedvarende smerter ved ett års 
oppfølging. Når det gjelder radiologiske faktorer, ble Modic type I forandringer vist å påvirke 
første del av forløpet hos pasientene med radikulær utstrålende smerte. En kjønnsavhengig 
effekt av opioid receptor mu 1 (OPRM1) A118G rs1799971 genotypen for smerte og 
funksjon etter lumbalt skiveprolaps ble også vist. 
 
Det konkluderes med at inflammatoriske, radiologiske og genetiske faktorer har betydning for 
sykdomsforløp ved radikulær utstrålende smerte etter lumbal skiveherniering. 
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1. Introduction           
 
1.1  Definitions and terminology 
The International Association for the Study of Pain (IASP) defines pain as: “…an 
unpleasant sensory and emotional experience, associated with actual  or  potential  
tissue  damage,  or  described  in  terms  of  such damage” [123, 124]. Thus pain is an 
experience with sensory, cognitive, and emotional components. The evolutionary function of 
pain perception is primarily detection of tissue damage. High-intensity heat, mechanical 
stimuli or chemicals that can produce such tissue damage are termed “noxious stimuli”, and 
are selectively detected by specific transducers called nociceptors localized at the peripheral 
nerve terminals. 
 
Nociception  refers  to  the  neural  process  by  which  noxious  stimuli  are detected by the 
nervous system. In contrast, the term pain is reserved for the psychological experience. Still, 
pain unpleasantness serves as a signal allowing avoidance of stimuli that can damage tissue. 
Thus, pain is an important physiological mechanism that increases the chance of survival. 
Unfortunately, pain can outlive its usefulness as a warning system, and can instead become 
chronic and debilitating. The transition to chronic pain involves mechanisms of peripheral and 
central sensitisation. Pain, similar to most experiences, can also be affected by psychosocial 
factors [84, 170]. Better understanding of the neurophysiologic mechanisms involved in the 
development and maintenance of pain will probably improve  future treatment of chronic pain 
conditions [118, 119]. 
 
Pain is often classified as nociceptive, inflammatory, neuropathic and noninflammatory/non-
neuropathic pain [103, 184]. Nociceptive pain arises from damage to non-neural tissue 
causing  activation  of  nociceptors. Inflammatory pain is also a response to tissue damage 
eliciting an immune response and inflammation which activates the nociceptors. 
Inflammatory pain may overlap with nociceptive pain, but do not involve nerve damage 
[184]. Neuropathic pain is in contrast defined as pain caused by a lesion or disease of the 
somatosensory nervous system [113, 168]. In neuropathic pain the warning system of the 
body itself is damaged. This neural damage results in sensory deficits and may in some 
patients leads to inappropriate nociceptive signaling to the brain that induces pain. Another 
pain category is noninflammatory/non-neuropathic  pain, such  as  in fibromyalgia,  tension- 
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type headache, irritable bowel syndrome, or temporomandibular disorder [103]. 
 
The term Low back pain (LBP) is used for pain localized in the low back, irrespectively of 
causes [172]. The term chronic LBP is used for duration of pain above 3 months [129]. 
LBP may be source of referred pain. Referred pain is pain in a region of the body 
topographically distinct from the region in which the actual source of pain is located. 
Referred pain from lumbar spine is initiated by activation of nerve endings innervating spinal 
structures such as discs, zygapophysial joints, or sacroiliac joints. The proposed  mechanism 
of referral is convergence of nociceptive afferents on second-order neurons in the spinal cord. 
The pattern of referred pain in the lower limb corresponds to the segmental innervation of 
deep tissues in the lower limb, such as muscles and joints [21]. 
 
Radicular pain, in contrast, is caused by activation of the nerve roots. This form of radiating 
pain has also been called sciatica. The taxonomy of the IASP recommends replacement of 
sciatica with the term “radicular pain” [21]. Moreover, radicular pain should not be mixed 
with the term radiculopathy. Notably, radiculopathy is characterized by objective signs of 
loss of neurological function (loss of sensory and/or motor function and/or diminished 
reflexes) as a result of conduction block in axons of a spinal nerve or its roots, but is not 
necessarily associated with pain. Still, radiculopathy and radicular pain commonly occur 
together and may also be caused by the same lesion. The present thesis will focus on radicular 
pain and associated LBP due to disc herniation (DH).  
 
1.2 Epidemiology and clinical presentation of lumbar radicular pain 
A large variation in the prevalence of lumbar radicular pain is reported in the literature due to 
a lack of strict definitive criteria [99, 161]. Several studies report a lifetime prevalence of 14–
40% for leg pain associated with back problems, but do not distinguish true radicular pain 
from the more common referred pain [67]. However, if stricter definitions of radicular pain 
are used the prevalence rate may be approximately 2% [38, 189]. Although lumbar 
radicular pain constitutes only 5–10% of LBP conditions [97], sick leave and disability 
benefits due to radicular pain account for 33% and 47%, respectively, of all back pain 
conditions in Norway [23]. 
  
Lumbar radicular pain is characterized by radiating pain in an area of the leg typically 
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innervated by one nerve root in the lumbar or sacral spine [95], and is evoked by ectopic 
discharges emanating from a dorsal root or its ganglion [124]. Radicular pain is typically 
caused by DH, but can also be due to mechanical compression of the nerve by a bone spur 
(osteophytes), thickening of surrounding ligaments or disc protrusion in case of lateral spinal 
stenosis. Patients with lumbar radicular pain often have LBP. Other less common causes of 
radilar pain are tumours or infections. Scoliosis can cause the nerves on one side of the spine 
to become compressed by the abnormal curve of the spine.  
 
The clinical presentation of lumbar radicular pain varies depending on the type and level of 
DH in lumbar spine and the affected nerve roots. Patients will often have pain in the lumbar 
region that radiates to one or both legs. Such leg pain is described typically as burning, 
stabbing, or shooting and is often exacerbated by coughing and sneezing. In radiculopathy, 
however, neurological signs are present such as weakness, numbness, or reflexive changes 
[165]. Clinical presentation for lumbar radicular pain, following a specific pain patterns in 
lower limbs, is well described and usually involves the L3, L4, L5 or S1 root [73]. DH often 
causes severe LBP.  
 
 
Diagnosis: The diagnosis of a lumbar radicular pain is based on symptoms and clinical 
examination findings. The neurologic examination, which includes an assessment of sensory, 
motor function and deep tendon reflexes in lower limbs and nerve stretch tests as straight leg 
raising (SLR), crossed SLR, reverse SLR, is important. However, the diagnostic accuracy of 
the SLR and crossed SLR tests is limited by its low specificity and sensitivity, respectively 
[37, 174]. Examination of a patient suspicious of cauda equine syndrome includes testing anal 
sphincter tonus and bladder function. 
 
 
The diagnosis of radicular pain due to DH may be confirmed by magnetic resonance 
imaging (MRI), alternatively computed tomography (CT) or CT myelography of lumbar 
spine. An MRI is more informative than CT because it also identifies other intraspinal 
pathologies. DH is defined on MRI as a localized displacement of disc material and can be 
classified as protrusion (mostly “focal” protrusions, not a “bulging” disc), extrusions 
(ruptured annulus fibrosus) or sequestrations (herniated disc material has no continuity with 
the disc of origin) [32, 46]. Electromyography (EMG)/neurography provide a more detailed 
assessment of nerve dysfunction, and is useful in diagnosis of radiculopathy. 
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Prognosis and treatment: The majority of patients with radicular pain due to DH have 
spontaneous regression of symptoms [13, 179]. Patients with persistent radicular pain lasting 
more than 8 weeks, neurological deficits (sensory changes, muscle weakness or depressed or 
absent deep tendon reflexes) and corresponding MRI findings of DH in the anticipated 
location may be assessed for surgical treatment. The surgery involves mostly partial removal 
of the herniated disc (microdiscectomy), rarely complete removal of the disc (discectomy). 
The utility of surgery for symptomatic lumbar DH is reviewed briefly. There is considerable 
evidence on the clinical effectiveness of DH surgery in patients that do not respond to 
conservative management [57]. Conservative treatment usually consists of activity guidance 
during the acute phase of symptomatic DH, use of analgesics and adjuvant analgesics, brief 
cognitive intervention, exercises and physiotherapy [110]. 
 
1.3 The intervertebral disc 
 
1.3.1 The normal anatomy 
The intervertebral disc (IVD) consists of the circumferential annulus fibrosus (AF) 
encapsulating the central nucleus pulposus (NP). The third component of the IVD is the 
vertebral endplate (EP), which comprises two layers of cartilage covering the top and bottom 
aspects of each disc.  
 
The AF consists of collagen Type I oblique fibres aligned in a lamellae. Within the lamella, 
the collagen fibres run parallel to one other, starting from the vertebra below and ending at 
the vertebra above. Each fiber forms a 65-70° angle from the vertical. Annulus cells are 
mostly elongated fibroblasts, some lying parallel to the lamellae and some rounded in 
shape. AF cells synthesize mostly proteoglycans and collagen [60]. The main proteoglycan in 
the IVD is aggrecan, which has high glycosaminoglycan content. 
 
The NP is a semifluid mucoid material, which consists of 70–90% water, although the exact 
proportion varies with age. Proteoglycans are the next major component, and they constitute 
approximately 65% of the dry weight of the NP. The water of the NP is contained within the 
domains of these proteoglycans. The majority of the proteoglycans are in the form of freely 
dispersed proteoglycan units that lack a functional binding site that would enable them to 
aggregate with hyaluronic acid, and only approximately 25% of the proteoglycans occur in an 
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aggregated form. Interspersed through the proteoglycan medium are thin fibrils of type II 
collagen, which serve to hold proteoglycan aggregates together. The mixture of proteoglycan 
units, aggregates and collagen fibres within the NP is referred to collectively as the matrix of 
the NP. Embedded in the proteoglycan medium of the NP are cartilage cells (chondrocytes) 
and some primitive notochordal cells, which disappear after approximately 10 years of age. 
The fluid nature of the NP allows it to be deformable under physical stress, but at the same 
time not compressible. Thus, under extreme loads, the NP deforms and distributes the weight 
in all directions, minimizing physical and structural damage. 
 
The intervertebral disc is the largest avascular tissue in the body, and the supply of essential 
nutrients including oxygen, glucose, and substrates for matrix production occur through 
diffusion. The metabolism of cells in the NP is very sensitive to changes in pH. They are 
maximally active in pH ranges of 6.9–7.2, but below 6.8 their activity falls sharply and 
below 6.3 their activity is only approximately 15% of the maximum. 
 
The organization of the IVD defines its response to mechanical stresses. The IVD serves three 
biomechanical functions. First, it sustains weight when transferring  a  load  from  one  
vertebra  to  the  next.  Second, it enables a rocking movement of the vertebrae by being 
deformable. Third, it provides the spine strength by withstanding ripping or breaking in 
situations of physical stress [60]. 
 
The vertebral EPs consist of a layer of cartilage and are approximately 0.6–1 mm   thick.   
The   EP   cartilage   is   made   up   of   hyaline   cartilage   and fibrocartilage. Hyaline 
cartilage is most prominent in the early developing stages of the disc and tends to appear on 
the outer portions of the IVD. Conversely, fibrocartilage is present more in older IVDs and 
further towards the centre of the disc. The EPs are recognisable as discrete entities at an 
embryonic stage in the development of the axial skeleton and remain as cartilaginous plates 
during the subsequent ossification of the vertebrae. In this early period, tiny blood vessels 
penetrating the EPs provide nutrition, not only for the cartilage itself, but also for the 
developing disc that eventually becomes enveloped by the AF and the vertebral body [127]. 
EPs function both as a mechanical barrier between the pressurized NP and the vertebral bone, 
and as a gateway for nutrient transport into the disc from adjacent blood vessels [169]. The 
creation of blood vessels in the EP is facilitated by the activation of enzymes such as 
matrix metalloproteinase (MMP), which are latent under normal conditions [62, 87, 127]. 
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MMP-3 (stromelysin) in particular has been detected at high concentrations in degenerate 
discs. 
 
1.3.2 Disc degeneration 
Disc degeneration (DD) is a multifaceted chronic process that alters the structure and 
function of IVDs. DD is probably initiated by damage to the AF or vertebral EPs, or by a 
cell-mediated reduction in proteoglycan content [3]. Deterioration of the AF is manifested as 
annular tears that can extend in different directions (radial,  transverse,  or  concentric)  and  
that  involve various depths of the AF. Radial tears or fissures progress outward from the NP, 
usually posteriorly or posterolaterally, and this process can be simulated in cadaveric discs by 
cyclic loading of bending and compression [1]. Radial fissures have been linked to ingrowth 
of blood vessels and nerve fibres [25] and are associated with DD. Deterioration of the AF 
and disc narrowing represent internal disc disruption and lead to “pathologic” discs [3]. 
Pathological DD is quite different from the normal aging process of the disc and often occurs 
in young individuals. With increasing age discs get harder and stiffer, because the mucoid 
matrix of the NP is progressively replaced by fibrous tissue. However, the disc height during 
normal aging of discs is maintained and radial tears or endplate defects are absent. Anterior 
osteophytes are also associated with the normal aging process of the discs. 
 
In contrast, pathological degeneration is unrelated to aging and is characterized by mixed 
endplate erosions and reactive osteosclerosis, gas in the  centre  portion  of  the  disc  
space,  disc  narrowing,  and  posterior osteophytes,  where  the  latter  is  always  
associated  with  a  posterior  disc rupture. DD is an aberrant, cell-mediated response to 
progressive structural failure. A degenerate disc is one with structural failure combined with 
accelerated or advanced signs of aging (not normal aging) [3]. Age and degeneration are 
nevertheless related, but degeneration has the greater effect on intradiscal stresses. In the early 
stages of degeneration, the cells make collagen and proteoglycans in an attempt to repair, but 
as the degeneration proceeds, synthesis slows down and the disc components break down. A 
decrease in proteoglycan synthesis leads to a loss of water, height, and hydrostatic pressure. 
Age-related degenerative changes reduce the sagittal diameter of the NP by approximately 
50%, and the pressure within it falls by 30%. The width of the NP increases by 80%, and 
compressive stress peaks within  the  posterior  AF,  which  is  affected  more  than  the  
anterior  AF, increase by 160% [2]. Over time, this can cause decreased flexibility and 
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strength. The degeneration process also involves an increase in the synthesis of catabolic 
molecules, such as MMP, which cause further degradation. 
 
 
Degenerative disc disease (DDD) applies to a degenerated disc that is also painful [3].  
Concentrated  areas  of  high  stress  in  the  posterior  AF  and presence of inflammation and 
granulation tissue in the AF, may be a cause of pain, and of further structural disruption [2, 
187]. DDD cases usually comprise patients with some radiological evidence (MRI) of DD and 
clinical symptoms, usually LBP and/or radicular pain. DDD includes lumbar DH that 
often leads to lumbar radicular pain and neurological signs as well as more definite 
radiographic evidence [77]. However, a generally accepted definition for DDD  and  its  
phenotype  is  lacking  [45,  120].  Common structural changes visualized on MRIs include 
radial fissures, radial bulging of the AF, reduced  disc  height,  osteophyte  formation,  
reduced  signal intensity (reflecting disc dehydration), and EPs defects [3, 48]. Complicating 
matter is the fact that the correlation of imaging findings with patient symptoms is weak and 
there is a high prevalence of abnormal neuroimaging findings in asymptomatic individuals 
[18, 42]. Factors contributing to the development of DDD include mechanical stress, 
nutritional factors, and genetic variables. Numerous studies have suggested that heredity is 
largely responsible for the development of lumbar DD [54], and that environmental factors 
play a much smaller role than previously believed [15, 45]. However, disc  height  changes  
seem not  to  be  were  not  heritable,  and  disc  signal changes is heritable only among those 
under 50 years [183].  
 
1.3.3     Vertebral endplate (Modic) changes 
Modic changes (MC) are defined as signal-intensity changes in the vertebral body marrow 
adjacent to the EP that are verifiable on MRI [34]. Three main forms of vertebral EP 
degenerative changes have been described [126]. Type I changes of the EPs are increased 
on T2 images and low on T1-weighted images  and  represent  vascular  fibrous  tissue,  
bone  oedema,  and inflammation, which contribute to more acute changes of DD. Type II 
changes are increased on T1-weighted images and iso- to hyperintense on T2-weighted 
images. Similar to type I changes, there is EP disruption when examined histopathologically. 
However, in contrast to the presence of vascularized fibrous tissue seen in type I changes; 
there is the presence of yellow marrow accounting for the shortening of the T1 signal. Type 
III changes, representing dense woven bone and absence of marrow, are decreased on both 
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T1- and T2-weighted images and correlate with sclerotic changes seen on spine radiographs 
[42]. A dynamic course of these MCs was demonstrated, where type I MC evolves into type II 
MC; however, a reverse process of type II into type I or to total absence is not unusual [6, 
74]. The incidence of new MC’s was reported as 6% in patients with conservatively treated 
DH over a 3-year follow-up [101]. 
 
The prevalence of all types of MCs increases with age, and is lower in nonclinical populations 
compared with patients with chronic LBP, with prevalence rates of 6% and 46–81%, 
respectively [10, 80]. Moreover, earlier observations indicate that the prevalence of MC’s in 
symptomatic DH varies between 25% in patients with acute lumbar radicular pain to 49% in 
patients 14 months after acute DH [7]. The prevalence of MC seems to be higher in patients 
with DH scheduled for surgical treatment compared with conservatively treated patients. For 
instance, Vredeveld et al. reported a prevalence of 32% for type I MC, 66% for type II MC, 
and 2% for type III MC in military men with lower lumbar DH who were scheduled for 
surgery (lumbar discectomy) [173]. In contrast, Albert and Manniche reported a prevalence 
of 9% for type I MC and 14% for type II MC in patients with present DH, who received 
conservative treatment [7]. There is evidence for an association between MC (particularly 
type I, but also type II) and LBP. Type I MCs have been shown to be both commonly 
observed in and associated with LBP [7, 80, 96, 102]. MCs may also play a role in the 
pathogenesis of lumbar radicular pain [7]. 
 
One explanation for the occurrence of MCs is that disruption of the internal architecture of 
the disc causes increased loading and leads to microfractures of the EPs (mechanical 
hypothesis). The cartilaginous EP is inclined to be damaged by mechanical injury, such as 
compressing forces, shear stress, and torsion [2, 3]. Histological examination of Type I MCs 
shows disruption, fissures, and vascular granulation tissue adjacent to the EPs [126]. EP 
cracks accompanied by increased vascular density and biological reactions to disc materials 
may lead to an inflammatory reaction during the early stages of DH and induce LBP, 
associated with type I MCs. Fayad et al. showed that patients with chronic LBP and 
predominantly Type I MCs had significant pain reduction 1month after intradiscal injection of 
corticosteroids (IDIC), compared to Type II MCs [47]. At 3 and 6 months, IDIC tended also 
to be more effective in the predominantly Type I MCs, but not significantly. This finding 
indicates the possible role of autoimmune reactions in type 1 MCs [116]. Ohtori et al. 
found significantly more protein gene product (PGP) 9.5- immunoreactive nerve fibres and 
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tumour necrosis factor alpha (TNFα) immunoreactive cells in vertebral EPs from patients 
with Type 1 or Type 2 MCs (especially in type 1) compared with LBP patients with normal 
EPs on MRI [131]. Bailly et al. has shown that LBP in patients with Type I MCs consists 
of an inflammatory pain pattern (i.e. presence of at least one of these three features: maximal 
pain on morning, waking at night because of pain, or morning stiffness for longer than 60 
min) [14]. 
 
Infection is another possible cause of bone oedema underlying type I MCs (bacterial 
hypothesis). Following a severe tear in the AF as in a DH, new capilarisation and 
inflammation occurs around the extruded NP. This special environment enables for anaerobic 
bacteria to enter the anaerobic IVD and develop low virulent infection [6]. Previous studies 
suggest discs infected with anaerobic bacteria are more likely to develop MCs in the adjacent 
vertebrae compared with those in which no bacteria or aerobic bacteria are isolated. Stirling et 
al. found that IVD material removed during surgery for lumbar DH (microdiscectomy) was 
infected with low virulence anaerobic organisms,  mainly  Proprionibacterium acnes  (P.  
acnes)  in  19  out  of  36 (53%) patients [163]. Distinguishing between a bacterial association 
with lumbar DH and contamination of the surgical wound by the normal skin microbiota 
is important in defining a microbial role. To eliminate possible skin contamination, Stirling 
et al. performed a prospective study using disc material harvested under stringent aseptic 
precautions from 207 microdiscectomy and 27 trauma, tumour, or scoliosis patients 
(controls). In the  microdiscectomy  group,  76/207  (37%)  patients  had  positive  cultures 
after  seven  days  incubation,  mainly  P.  acnes,  of  which  26  (34%)  had positive serology. 
Conversely, no (0 %) bacteria were found in the extracted IVDs from the control group [162]. 
Theoretically, if skin contamination was the cause of bacterial presence in the IVD then the 
percentage of infected patients should be very similar. However, other researchers still posit 
that P. acnes found in IVDs is a skin contaminant [28, 121]. 
 
Albert et al. hypothesized that these anaerobic mouth and skin commensal organisms gain 
access to the disc during normal bacteremia as a result of the neovascularisation associated 
with DD or herniation [6]. Local inflammation in the adjacent bone may, in this case, be a 
secondary effect due to cytokine and propionic acid production, i.e., the infection is in the 
IVD and the MC is a “side effect’’ manifest in the bone. P. acnes cannot live in the highly 
vascularised/aerobic bone and is not present there [180]. Albert et al. has shown that patients 
with LBP and type I MC due to DH, who were treated with antibiotics (amoxicillin-
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clavulanate 500 mg/125 mg, 3 × daily for 100 days) showed statistically significant pain 
reduction compared with the placebo group [8]. Thus, treatment with certain antibiotics is 
significantly more effective compared with placebo against LBP due to type I MC. If 
these findings are replicable, they could fundamentally change the concept of type I MC 
associated LBP and, consequently, treatment strategies [20]. Historically, bacteria have been 
implicated in the pathogenesis of other conditions  that  do  not  primarily  present  as  
infectious  diseases,  such  as gastric ulcers. Conversely, most antibiotics, including β-lactams 
have anti- inflammatory effects [9, 181]. Fayad et al. reported that pain relief after an 
intradiscal injection of corticosteroids does not support an infectious origin of the type I MC 
[47]. However, it is imperative to confirm these results in different settings before antibiotics 
are routinely prescribed for chronic LBP due to type 1 MC. Moreover, treatment with 
antibiotics may be relevant only for patients with type 1 MC who represent a relatively small 
group of LBP patients. In addition, the use of broad spectrum antibiotics over a long period 
may lead to the development of antibiotic resistance [159], which at the present time is a 
significant global concern. 
 
Regarding operative treatment of patients with MCs, a previous study has suggested that 
patients with radicular pain due to DH with and without type I MCs have similar long-term 
recovery profiles of back pain after lumbar discectomy surgery [132]. In contrast, another 
study has shown that patients with type I MC had less improvement of back pain 1 year after 
microdiscectomy, compared with those who had no or other types of MC, but not if they 
smoked cigarettes [158]. In more extensive spinal surgery, better results of anterior fusion 
were observed for LBP patients with DDD in patients with type I MCs [29]. In addition, type 
I or II MCs were reported as one of the best predictors of success after disc prosthesis surgery 
[71].  
 
1.4 Pathoanatomy and pathophysiology of disc herniation (DH) 
Neo-angiogenesis and neurogenesis in the annular tears is associated with inflammation. This 
sensitizes nociceptors in the AF, which affects DRGs, and causes LBP or radicular pain 
[49, 187]. Both annulus tears and EP junction failure (EPJF) lead to lumbar DH. The EPJF 
defines radiological as vertebral corner defect, rim avulsion, frank bony avulsions, and 
avulsion at both upper and lower EP. Rajasekaran et al. has shown in a multimodal in vivo 
study that lumbar disc herniation (LDH) is more often the result of EPJF  than AF 
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rupture [145]. This study confirms that EPJF by avulsion is the main cause of lumbar DH. 
The incidence of EPJF was 58% when only preoperative radiological assessment was 
considered, but increased to 65% when intraoperative findings of cartilage avulsion were 
added. The evidence of EPJF opens up potential opportunities for prevention of progression 
of lumbar DH after the initial event of EPs avulsion. 
 
DH leads to an injury-induced inflammation mediated by biochemical and immunological 
factors, which determine the pathophysiology of radicular pain [22, 39, 128]. Several 
studies have shown an increasing role of inflammatory cells [63], immunoglobulins and pro-
inflammatory agents include   phospholipase   A2    [53],   MMPs   [87],   prostaglandin   E2     
[87], leukotriene   B4   and   thromboxane   [130],   nitric   oxide   (NO)   [68,   86], 
interleukin 1α (IL-1α) [155], interleukin 6 (IL-6) [87], interleukin 8 (IL-8) [27],  
interleukin  12  (IL-12)  and  interferon  γ [65],  TNF- α [5],  and cyclooxygenases   (COX)   
[86].   NP   tissue   contact   with   the   systemic circulation in DH leads to lymphocyte 
activation with secretion of Interferon Gamma (IFN-gamma) and macrophage recruitment. 
Macrophages are specially involved in the regression of DH [76]. Further, 
neovascularization in herniated disc tissue may promote the formation of granulation tissue 
and deposits of immunoglobulins in association with blood vessels [66]. The disc material 
stimulates the production of IgM and IgG antibodies [160], particularly to the 
glycosphingolipid of nerve roots. TNF-α has been suggested to play a key role in NP 
mediated nerve root injury. TNF-α alone, or in combination with other cytokines, has been 
demonstrated to stimulate NO production. NO is also involved in the pathophysiological 
effects of NP in DH, through a variety of biological events including vasodilation, 
neurotransmission, cytotoxicity, gene regulation, vascular permeability, and blood flow 
alterations, and recruitment of inflammatory cells. In addition, application of NP induces a 
decrease in nerve-conduction velocity in spinal nerve roots after only a few days. This 
indicates a relatively rapid mode of action in terms of the functional effects of NP on nerve 
roots [26]. Taken together, the inflammatory reaction around the herniated disc material 
leads to an injury to the nerve root with consequent disturbance of intraradicular blood flow 
and breakdown of the blood-nerve barrier, resulting in intraradicular inflammatory changes 
such as edema and demyelination [39]. 
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1.5 Radicular pain mechanisms 
Historically, Mixter and Barr in 1934 described disc-related sciatica as a consequence of 
compression of the nerve root due to DH [125]. More recent research has shown that only if 
nerve roots have been previously inflamed does mechanical stimulation evoke radicular pain 
[156]. Specifically, mechanical compression of a healthy nerve root caused dysesthesia, 
paresthesia, or motor loss, but no pain. Compelling evidence from animal models has shown 
that mechanical compression of either the dorsal root ganglion (DRG) or of chronically 
injured roots can induce prolonged repetitive firing in sensory axons [72]. Studies in rats, 
using pain behaviour assessment, have indicated that the NP may well be involved in pain 
production. Pain behaviour in this context refers to response thresholds to thermal and 
mechanical stimuli. Further, Olmarker et al. provided the first evidence that the NP may 
induce nerve tissue injury by mechanisms other than mechanical compression [134]. Such 
mechanisms may be based on direct biochemical effects of the NP components on nerve 
fibre structure and function, and microvascular changes including inflammatory reactions in 
nerve roots, in the absence of mechanical compression [134]. Kawakami et al. also showed 
that a three-level laminectomy and an application of homologous NP or AF taken from discs 
in another rat, and applied at three nerve roots, produced pain behaviour [92]. Application of 
NP to nerve roots increases endoneurial fluid pressure (EFP) and decreases blood flow in the 
associated DRG, resulting in intraneural oedema in NP-treated nerve roots and DRG [185]. 
NP exposure and displacement at the nerve root level produced more behavioural changes 
compared with NP exposure and displacement of the DRG [51]. 
 
In animal studies, application of NP to nerve roots induces inflammatory changes in the form 
of increased vascular permeability, oedema, and intravascular coagulation [133, 185]. 
Inflammation damages nerve roots, blocks nerve conduction, increases nociceptive activity in 
the pain pathways and produces hyperalgesia and pain behaviour [41, 91, 139]. The 
mediators of this inflammatory response are phospholipase A2, NO, and TNF-α [41, 75, 90]. 
However, both chemical and mechanical factors are needed to induce radicular pain. These 
factors likely exert a synergistic effect where chemical factors may play the predominant role 
early in the pathogenic process [128, 135]. In addition, in Olmarker et al’s model, pain 
behaviour was present when disc incision was combined with a slight medial displacement of 
the nerve root or DRG. The combined action of disc incision and slight mechanical 
deformation induced statistically verified changes, whereas each of the two injuries by 
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themselves did not. 
 
 
The LBP, associated with DH, may primary arise from the discs, but can also occur from 
facets, muscles, or vertebrae. Degenerated lumbar discs, a high intensity zone (HIZ) in the 
disc, facet arthropathy, and Modic changes in the vertebral bone marrow are associated with 
LBP [31]. Changes in paraspinal muscle morphology, smaller multifidus muscle cross-
sectional area, and greater fatty infiltration are also related to LBP [52]. In spite of the fact 
that LBP likely arises from a physical process in the back and ensuing nociception, 
development of chronic LBP and disability depends more on psychological factors than on the 
physical condition of the back, and can be understood and managed by a biopsychosocial 
model [175, 176]. As pain becomes chronic (longer than 12 weeks) attitudes and beliefs, 
distress, and illness behaviour play an increasing role in the development of chronicity. 
 
1.6 Pain modulation 
The healthy brain maintains a dynamic balance between endogenous pain suppression and 
pain facilitation. This balance likely accounts, in large part, for inter-individual differences in 
pain response and day-to-day variation due to life circumstances [122]. Under extreme 
conditions such as trauma and stress, endogenous pain controls can be strongly activated; 
blocking the pain experience even in the presence of severe injury [122]. A shift towards 
facilitation (e.g. nocebo, hypervigilance, or catastrophizing) which increases pain  may  also  
occur.  It  is  widely  believed  that  reduced  background inhibition and an enhanced “tone” 
of facilitation can cause chronic pain conditions  [58,  103].  The  pain  system  involves  the  
peripheral  nervous system (PNS), which generates pain-provoking signals, and the central 
nervous system (CNS), which integrates these signals and relays them to a conscious brain in 
a “bottom-up” process. Increased responsiveness and a reduced threshold of nociceptive 
neurons in the periphery to stimulation represent peripheral sensitisation. In response to 
inflammation or nerve injury, the somatosensory system may increase its sensitivity, 
resulting in a maladaptive response. Thus, innocuous stimuli generate an amplified response 
[25]. Nociceptors conduct nociceptive signals via the nociceptive Aδ- and C-fibres, which 
make synaptic connections with neurons in the dorsal horn of the spinal cord. However, 
irrespective of origin these signals are modulated. The first possible level for impulse 
modulation is the DRG and spinal dorsal horn [25]. Subsets of dorsal horn neurons, in turn, 
project axons and transmit pain messages to higher brain centres, including the reticular 
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formation, thalamus, and ultimately the cerebral cortex [83]. Most frequently the signals are 
inhibited at the spinal and/or supraspinal level. Central sensitisation in contrast is defined as 
increased responsiveness of nociceptive neurons in the CNS to their normal or 
subthreshold afferent input [123]. 
 
Pain is also influenced by a “top-down” mechanism of pain modulation. The descending 
modulation is controlled by supraspinal structures such as the amygdala, periaqueductal grey 
(PAG), and rostral ventromedial medulla (RVM). Consistent with this, several investigations 
have noted a relationship between abnormalities  in  descending  modulation  and  clinical  
pain syndromes, including DH with radicular pain. Descending pain control can be 
experimentally assessed and is termed conditioned pain modulation (CPM); previously named 
diffuse noxious inhibition control (DNIC) and "pain-inhibits-pain". The DNIC system is a 
spinal-bulbo-spinal pathway that was first described in animals by Le Bars et al. over 30 years 
ago [108]. Its proposed general function is to inhibit ongoing pain in remote areas when a 
new pain stimulus is introduced [107]. The anatomical basis of the DNIC system is less 
clear in humans, suggesting the involvement of the PAG- RVM  network  rather  than  
more  caudal  regions.  Descending  inhibitory effects  are  evoked  by  painful  heterotopic  
conditioning  stimuli  (thermal, mechanical, electrical, or chemical) resulting in decreased 
pain perception induced by painful stimulation given elsewhere in the body than the 
heterotopic stimulus. CPM is impaired in populations with chronic pain in comparison to 
healthy individuals, especially in comparisons of younger populations and when only female 
participants are involved [111]. Stress- induced  analgesia  (SIA)  is  a  second  endogenous  
pain  control  paradigm where, for example, an injured soldier or accident victim transiently 
reports feeling much  less  pain  than  would  be  expected  given  the  extent  of  the wounds  
[122,  188].  Further,  the  placebo/nocebo  effects  (and placebo/nocebo-like effects) work by 
engaging endogenous pain modulatory circuits in the same way that opiate drugs, 
CPM/DNIC, and SIA do. Activation of opioid receptor mu 1 (OPRM1) in the PAG-RVM 
network may activate descending inhibitory pathway. Hence, pain is moderated by 
endogenous CNS networks, which can be activated by a large variety of cognitive, emotional 
and behavioural paradigms [146].  Increased knowledge of endogenous opioid or non-
opioid pain control mechanisms and how to exploit them can contribute to better pain 
medicine. 
 
Approximately 25% of patients with LBP develop widespread pain over a period of 18 
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years [104]. The underlying mechanism and nature of the predisposing risk factors have yet to 
be discovered, although both neurophysiological and biosocial (psychological) explanations 
have been proposed [150]. There are no definitive models explaining the transition from 
localised pain due to tissue challenges (e.g. damage) to widespread pain conditions, 
although intramuscular injection of nerve growth factor causes long lasting muscle 
hyperalgesia with some signs of spreading sensitisation [56]. 
 
It is likely that initial excitation and sensitisation of nociceptors due to tissue damage will 
cause sufficient nociceptive input to the central pain systems, leading to sensitisation of 
dorsal horn neurones and/or higher brain centres. In various types of chronic pain, 
diminished inhibition in the spinal dorsal horn  is  believed  to  be  a  major  contributor  to  
chronic  pain.  Diminished activity of the descending monoaminergic pathways controlled by 
opioid systems in the PAG and brainstem, and decreased inhibitory interneuron activity 
caused by reduced synthesis of inhibitory neurotransmitters (γ- aminobutyric acid (GABA) 
and glycine) or loss of interneurons, may contribute to chronic pain [50, 103]. Monoamines, 
including serotonin, norepinephrine, and dopamine,  modulate the release of 
neurotransmitters from nociceptive afferents and the excitability of dorsal horn neurons by 
binding to different receptor subtypes. Hence, alteration of serotonergic pathway induces a 
hyperexcitability of spinal dorsal horn neurons by activation of spinal 5-HT2 and 5-HT3 
receptors. Further, decreased activity of serotonergic descending pathway exerts both 
antinociceptive and nociceptive effects on pain and contributes to chronic inflammatory pain 
[190] and postoperative pain [153]. Unlike serotonergic pathways, the descending 
noradrenergic pathway has only antinociceptive effects by activating α2  receptors 
(presynaptic inhibition) on primary nociceptors. Activating of postsynaptic α1 receptors may 
also contribute to antinociception,  by  causing  the  release  of  inhibitory  
neurotransmitters (GABA or glycine) from inhibitory interneurons [17]. Hence, alteration 
of noradrenergic pathway contribute to increase pain perception [103]. The role of  the  
dopaminergic  pathway  in  chronic  pain  is  less  studied,  but  thus pathway may affect 
spinal nociception due to the effects of dopamine and activation  of  D2   and  D3   
receptors  on  primary afferents  and  dorsal  horn neurons [55, 103]. 
 
Neuroimaging studies have identified several brain areas that are considered to be important 
for the perception of pain. The primary and secondary somatosensory cortices (insular and 
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anterior cingulate) and the prefrontal cortices (PFCs) are commonly activated, often 
bilaterally, and during painful experiences [109]. Furthermore, altered activity in subcortical 
areas (e.g. PAG, hypothalamus, amygdala, hippocampus, and cerebellum) is also observed 
during pain [109]. Thus, activity within several diverse regions of the brain contributes to the 
multidimensional experience of pain. These regions comprise the so-called ‘pain 
neuromatrix’, in which multiple inputs are processed to produce an output (neurosignature) 
that is bespoke for an individual depending on context, mood and cognitive state [167]. 
However, none of the brain regions identified above is uniquely associated with pain; they  
are  also  involved  in  many  other  sensory,  motor,  cognitive,  and emotional functions. 
Altered structure, function and neurochemistry in the frontal-limbic-brainstem   regions   have   
been   revealed   in   neuroimaging research in patients with chronic pain compared with 
healthy controls. Neuroimaging   can   improve   our   understanding   of   pain   mechanisms, 
analgesic action and the placebo effect [109]. Further, neuroimaging might identify  
functional,  structural  or  biochemical  endophenotypes  for  pain, linking pain conditions 
to genotype [61, 166]. These pain endophenotypes could 'fill the gap' between pain behavior 
and the genes, improving our knowledge about the etiology of pain [166]. 
 
1.7 Prognostic factors for lumbar radicular pain 
The recovery from lumbar radicular pain is influenced by psychosocial, emotional, surgery-
related, and clinical factors [35, 69, 117]. Psychosocial and emotional prognostic factors 
have been less well studied in radicular pain compared with LBP [12, 98], but they do have 
an impact on recovery. Comorbid subjective health complaints, emotional distress, 
kinesiophobia, biological  factors,  more  LBP,  longer  duration  of  symptoms,  smoking, 
clinical factors such as muscular weakness, and no surgical treatment are associated with 
non-success in lumbar radicular pain due to DH [40, 69, 158]. Lower educational level is 
also associated with poor recovery from LBP [93], and may influence recovery after DH. 
Lower education level is often associated with environmental factors such as heavy physical 
work and low-decision authority, which  are  known  prognostic  factors  for  poor recovery 
[30, 93]. In surgically treated patients with DH, high treatment expectancy is associated with a 
favorable outcome, whereas taking pain medication, a poor functional status, high leg pain 
and LBP at baseline are associated with poor perceived recovery and functional status at 1-
year follow-up [140]. Radiological factors may predict outcome in surgically treated patients 
with DH. Patients with one third or more thecal sac compression had a greater surgical 
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treatment effect compared with patients with small DHs and type I MCs. In addition, patients 
with nerve root "compression" and "displacement" were shown to benefit more from surgery 
compared with patients with minimal nerve root impingement [115]. 
 
Occupational factors (e.g., heavy physical work, lifting heavy objects, bending over and 
twisting, whole-body vibration, and static operating position) can induce DD. Subsequently, 
the intradiscal pressure is increased and the AF strength is reduced predisposing for DH. 
However, the psychosocial factors at work like high professional pressure and lower job 
satisfaction as well as time-related stress are equally well-known risk factors for DH [192]. 
The biomechanical mechanisms behind this association is however unknown. It is also 
believed that the interaction of environmental and  genetic  factors  influences  the  
development  of  DH  as  well  as  the recovery of DH [193]. 
 
1.8 Genetic concepts and impact of genetic factors 
Genes are parts of DNA molecules that contain the information used by cells to construct 
protein molecules. Proteins are “products” of gene transcription and translation, the two 
cellular processes that exploit the information encoded in the sequence of base-pairs in the 
DNA molecule to manufacture particular   proteins.   DNA   in   human   genome   is   
organized   into   23 chromosome pairs and in most cases has nucleotide base-pair sequence 
of A (Adenine) - T (Thymine) - C (Cytosine) and G (Guanine). The Human Genome Project 
produced the first complete sequences of individual human genomes. As of 2012, thousands 
of human genomes have been completely sequenced, and many more have been mapped at 
lower levels of resolution. There  are  approximately  3  billion  DNA  base  pairs  containing  
20.687 protein-coding genes and their variants in the human genome [142]. 
 
Variations  in  the  DNA  sequence  between  genomes  make  each  human unique. The mix-
and-match combination of the alleles we carry makes us genetically different  from  each  
another.  Genes may  therefore  be polymorphic. A genetic variation with a frequency of 
more than 1% in the population is called a polymorphism [58]. In many cases only one base 
pair is  changed,  for  example  GC  may  be  replaced  with  AT.  This  kind  of variability is 
called a single nucleotide polymorphism (SNP). SNPs result in a substitution of a single base 
pair which can have important functional effects. Hence, genetic polymorphism may affect 
the pain signaling and modulatory system [58]. Genetic variability may also be important for 
 29 
 
development of chronic pain conditions [58]. 
 
Genetic influence in aetiology of chronic lumbar radicular pain due to DH consists of genetic 
risk factors for lumbar DD, cytokine release promoting genes and pain modulating genes. 
During the last two decades heredity of DD has been investigated in twin studies, which 
have identified positive familial aggregation, suggesting some degree of genetic influence 
[120]. In one of the first studies, genetic component of DD was determinate in 115 pairs of 
male monozygotic twins [15]. Familial aggregation explained 61% and  34%  of  the  variance  
in  degeneration  scores  in  the  upper  (Th12-L4 region) and the lower lumbar levels, 
respectively [15]. A more recent article by Battie et al [16] summarized the Twin Spine Study 
and confirms that genetic factors are a larger determinant of DD. Another twin study 
involving 172 monozygotic and 154 dizygotic twins found similar results [148]. In this study 
the summary degeneration score, which included height, signal intensity, bulging, and 
osteophyte formation demonstrated heritability estimates up to 74% for the lumbar spine 
and 73% for the cervical spine after adjusting for age,  weight,  height,  occupation, and  
physical activity [148]. A “severe DDD score”, which excluded minor grades, estimated 
heritability to be 64% at the lumbar and 79% at the cervical spine [148]. 
 
Moving on to association studies the specific risk factors for DD and LBP may be studied 
by two approaches: Genome wide association (GWA) and candidate gene studies. The first 
GWA study on lumbar DD provides evidence of association between the parkin-2 (PARK2) 
gene and DD [182]. PARK2 encodes a protein called parkin, which is a component of a 
multiprotein E3 ubiquitin ligase complex that mediates the targeting of unwanted proteins for 
proteasomal degradation. This complex also controls the level of proteins involved in cell 
division and growth. Williams et al [182] have shown that PARK2 expression is reduced 
with increasing DD. Furthermore, associations between lumbar DD and the several candidate 
genes have been reported [4, 120]. These genes are divided into five categories based on 
potential function of the proteins encoded by genes [120] (figure 1): 
 
1) Structural:  Aggrecan  genes  (AGc1),  cartilage  intermediate  layer protein (CILP),         
collagen I (COL1A1), collagen IX (COL9A2 and COL9A3), collagen XI (COL11A2); 
2) Catabolic: MMP1, MMP2, and MMP3; 
3) Anticatabolic: Tissue inhibitors of metalloproteinase (TIMP); 
4) Inflammatory: ILs, COX2; 
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5) Other genes: Vitamin D receptor (VDR) gene, apoptotic genes FAS, FAS ligand, and    
    B-cell lymphoma 2.   
 
 
 
 
 
Fig. 1. Functional gene categories. This figure depicts the functional categories of the genes 
and the relationships between their protein products. From J.E. Mayer et al. [120]. 
Stimulation is indicated by → and negative impact is indicated by ┤. 
 
Regarding structural genes, polymorphisms of the gene encoding aggrecan have been found 
with varied levels of DD [89]. The expressed variable numbers of repeats occur in a highly 
conserved region of the gene: The glycosaminoglycan (GAG) binding domain, which binds 
mostly chondroitin sulphate. It is thought that aggrecan alleles with a shorter variable number 
of tandem repeat (VNTR) length increase the risk of DD at younger ages [89]. Further,  the  
most  obvious  effect  of  this  VNTR  is  variable  chondroitin sulphate content in IVDs, with 
a 33% variation between the shortest and longest VNTR length. A diminished chondroitin 
sulphate content at an early age can lead to degeneration of the IVD matrix [60]. Other 
structural genes that have been associated with DD are genes COL9A2, COL9A3 and 
COL11A2 and CILP [45, 85]. 
 
Regarding catabolic genes, MMPs represent key proteins involved in the breakdown of the 
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extracellular matrix. MMP expression has been shown to increase   with   age,   which   
correlates   with   an   associated   increase   in degradation [11, 120]. The increase in MMP 
expression often corresponds with the severity of degeneration. Polymorphisms in MMP1, 
MMP2 and MMP3 have been studied as risk factors for DD. In addition, MMP3 was found to 
be associated with post treatment improvement in disability and pain in LBP patients 
[137]. From anticatabolic gene group, so far only TIMP polymorphism has been studied in 
association with DDD [120]. The balance between catabolic and anticatabolic enzymes is 
delicate and a slight increase in  the  catabolic  or  decrease  in  the  anticatabolic  enzymes  
could  tip  the balance in favor of DD [120]. 
 
Inflammatory genes, including genes encoding ILs and COX2, may be associated with 
predisposition for DD [105], DH and lumbar radicular pain [141]. IL1 has an important role 
in the degradation of matrix proteins. Increased expression of IL1 has also been observed in 
the degenerated discs. In  normal  discs,  endogenous  IL1  receptor  antagonists  exert  a  
negative impact.  In  DD,  this  negative  control  is  not  significant  because  IL1 
expression increases, whereas IL1 receptor antagonist does not. Further, a specific effects of 
the IL-1α SNP C>T (rs1800587) in early lumbar DD have been suggested [43, 44]. Patients 
with the IL-1α T genotype seem to have overall enhanced levels of IL-1α, resulting in an 
increased activation of IL-1 receptors and a more pronounced inflammatory response. 
Actually, the IL-1α is a very strong inducer of inflammation, and causes a broad spectrum of 
systemic changes in neurological, metabolic, hematological, and endocrinological  systems.  
Another  IL-1α  polymorphism  (rs2071375)  has been found to be associated with the 
changes in disc signal intensity [171]. There are also many IL-β and IL6 polymorphisms 
that may be associated with DD [88, 120, 141]. 
 
Genes controlling pain, so-called “pain genes” have been emerged from discoveries of 
underlying genetic causes of distinct phenotypes. Among the best-known “pain genes” are 
those which cause human hereditary disease associated with extreme pain phenotypes. Such 
genes are carried by less than 1% of the population, which contrasts greatly with the 20% of 
adults in Europe suffering from chronic pain [24]. Gene polymorphism of pain modulating 
genes is more important for development of chronic pain conditions. Lötsch et al [114] has 
shown by analysing 410 genes which control the complex process of pain, that 12 clearly 
circumscribed functional areas  of  DNA  are  essential  for  pain  perception.  Pain  
modulating  genes include genetic factors, affecting the endogenous pain modulatory system, 
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such as the OPRM1 rs1799971 gene polymorphism [136]. A decade ago Zubieta et al. [194] 
described  the  impact  of  the  Catechol-O- methyltransferase (COMT) polymorphism 
(Val158Met) rs4680 on the relationship between pain perception and the mu-opioid 
neurotransmitter response, and found that volunteers with the Met/Met genotype exhibited 
higher sensory and affective ratings of experimental pain, and also had a higher regional 
density of mu-opioid receptors. Moreover, the COMT gene polymorphism contributes to 
treatment outcome of LBP [33, 138] and long-lasting LBP, radicular pain and disability after 
lumbar DH [79]. The IL-1α gene polymorphism may also possibly increase the spinal 
nociceptive signaling [155] and modify the cytokine profiles of patients with inflammatory 
diseases [70]. 
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2. Aims of the study          
 
 
The main purpose of this study was to investigate prognostic factors for recovery after 
lumbar radicular pain due to DH. 
 
Specifically I aimed to: 
 
1. Identify predictors for functional outcome, especially to investigate the influence of 
cytokines (IL-6 and IL-8) at 1-year recovery in patients with lumbar radicular pain. 
 
2. Examine how variability of the IL-1α C>T rs1800587 gene affects the pain 
intensity and pressure pain threshold (PPT) in patients with symptomatic DH. 
 
3. Examine whether Modic changes influence pain during one-year follow-up in 
patients with lumbar radicular pain. 
 
4. Investigate the interaction between sex and the OPRM1 A118G variant rs1799971, 
regarding recovery from DH. 
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3. Methods            
 
 
3.1. Study population 
Participants with lumbar radicular pain were recruited from patients of the Oslo  University  
Hospital,  Ulleval  (papers  I  and  II),  and  from  Oslo University Hospital, Ulleval, and 
Haukeland University Hospital (papers III and IV) between 2007 and 2009. The inclusion 
criteria were as follows: aged between 18 and 60 years, lumbar DH on MRI with 
corresponding distribution of pain in lower limbs, and positive straight leg raising (SLR) 
test results. A positive SLR test was defined as radiating pain into one or both legs when 
the examiner raised the straightened limb slowly until 60°. The test was performed in a 
supine position and supplemented with slight dorsiflexion of the foot. 
 
The exclusion criteria were as follows: lumbar spinal stenosis, previous spinal surgery 
for a herniated disc at the same level or lumbar fusion at any level, generalised 
musculoskeletal pain, inflammatory rheumatic disease; diabetic  polyneuropathy,  
cardiovascular  disease  (New  York  Heart Association class III and IV), cancer, psychiatric 
disease, drug misuse and alcoholism, recent surgery (within 1 month), pregnancy, poor 
proficiency in the Norwegian language, and non-European-Caucasian ethnicity. Patients with 
cauda equina syndrome were also excluded. 
 
In papers I and II, 121 (81.8%) of the 148 patients who met the eligibility requirements were 
included in the intended follow-up assessment. The drop- out rate was 9%, and ultimately, 
110 patients were assessed at the 1-year follow-up. In paper III, a total of 262 (87.6%) of 
the 299 patients assessed for eligibility were included.  However,  because  19 patients  had  
missing baseline data, 243 (81%) of the 299 patients were allocated to follow-up. Only 18 
(7%) of the 243 patients dropped out of the study. In paper IV, the study population consisted 
of 252 patients allocated to follow-up. A total of 21 (8%) patients dropped out. 
 
3.2. Follow-up and clinical assessment 
Table 1 shows follow-up times, which in paper I was 12 months, paper II 6 weeks and 12 
months, and in paper III and IV three follow-ups at 6 weeks, 6 months, and 12 months. 
Treatment (surgery or conservative) was decided during the initial screening visit (inclusion) 
where surgical treatment was given to patients with persistent radicular pain lasting longer 
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than 8 weeks, neurological deficits (sensory changes, muscle weakness, or depressed or 
absent deep tendon reflexes) and corresponding MRI findings in the anticipated location. 
Non-surgical treatment was given to patients that did not clearly meet these criteria. Non-
surgical treatment comprised brief cognitive intervention, activity guidance during the acute 
phase of lumbar radicular pain, and physiotherapy for most of the patients. Initiation of 
treatment occurred within 8 weeks after inclusion. A few patients had to wait for surgery 
longer than 8 weeks and were re-included with additional clinical parameters. A total of 37%, 
52%, and 58% patients received surgical treatment in papers I - II; III, and IV, respectively. 
 
 
 
Table 1. Follow-up and clinical assessment in the studies 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Allocated to follow-up 
**Within 8 weeks from inclusion 
 
 
Data  collection  included  clinical  examination  with  observation  of  the patient's casual 
gait, toe- and heel-walking, assessment of reflexes, sensory, and motor function in the lower 
limbs. Pain-related questionnaires, such as the visual analogue scale (VAS) for present pain, 
pain during activity, pain at rest with separate VASs for LBP and radicular pain, and the 
validated Norwegian version of the McGill Pain Questionnaire (MPQ) were administered. 
The MPQ measures sensory, affective, and evaluative components of the pain experience 
[164]. The validated Norwegian version of the Oswestry disability index (ODI) (scale, 0–
100%, where 0% = no disability  at  all,  and  100%  =  very  severe  disability)  was  
 Pre-treatment 
(inclusion) 
Tr
ea
tm
en
t*
* 
Follow-up 
6 weeks 6 months 12 months 
Paper I 
(n*=121) 
    
Paper II 
(n*=121) 
    
Paper III 
(n*=243) 
    
Paper IV 
(n*=252) 
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used  for measurement of function [64]. Use of analgesics and adjuvant analgesics were 
registered.  
 
Sociodemographic variables and work-related factors such as marital status, duration of 
education, occupation, duration of sick leave, and social benefits were also registered upon 
inclusion in the study. Occupations were classified into three groups: mental, mixed, and 
physical work [78]. The demand and control subscales of the General Nordic Questionnaire 
for Psychological and Social   Factors   at   Work (QPS   Nordic)   were   administered   to   
record quantitative job demands and the control of work pacing [177]. The Hopkins Symptom 
Checklist (HSCL), a 25-item questionnaire, was used to register psychological distress [36]; 
scores equal to or greater than 1.75 on the total scale indicated emotional distress [149]. 
Radiological data (lumbar MR) and blood samples were also collected. 
 
The patients were followed-up at 6 weeks, 6 months, and 12 months after inclusion. At 6 
weeks and 12 months, clinical examination, registration of pain and disability scores, work 
status, and collection of blood samples were repeated. At the 6-month follow-up, patients 
were contacted by telephone regarding changes in their spinal condition and work status, 
and were sent the VAS, McGill, and ODI questionnaires by mail. In cases of persistent 
radicular pain, MRI of the lumbar spine was repeated at 12 months. Table 2 shows when and 
in which papers the different measures were administered. 
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Table 2. Data collected and used in papers I, II, III and IV 
 
 Baseline Follow-up after treatment 
6 weeks 6 months 12 months 
Clinical 
examination 
 
I, II, III, IV 
 
II, III, IV 
  
I, II, III, IV 
 
VAS back pain 
 
I, II, III, IV 
 
II, III, IV 
 
III, IV 
 
I, II, III, IV 
 
VAS leg pain 
 
I, II, III, IV 
 
II, III, IV 
 
III, IV 
 
I, II, III, IV 
 
ODI 
 
I, II, III, IV 
 
II, III, IV 
 
III, IV 
 
I, II, III, IV 
 
McGill (MPQ) 
 
III, IV 
 
III, IV 
 
III, IV 
 
III, IV 
 
HSCL-25 
 
I 
   
I 
 
QPS Nordic 
 
I 
   
I 
 
Sociodemographic 
 
I, II, III 
 
II, III 
 
III 
 
I, II, III 
 
Work-related 
 
I, II, III 
 
II, III 
 
III 
 
I, II, III 
 
Use of analgesics 
 
I, II, III 
 
II, III 
 
III 
 
I, II, III 
 
PPT 
 
II 
 
II 
  
II 
 
MRI 
 
I, III 
   
* 
 
Genotyping 
 
II, IV 
   
** 
ELISA 
measurement of 
cytokine in serum 
 
I 
   
 
** 
 
*MRI of the lumbar spine was repeated at 12 months follow-up for patients with persistent 
radicular pain, but was not used in paper II or III. 
 
**Blood samples were also collected at 12 months follow-up, but not analysed. 
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3.3. Outcome measures 
Pain and disability related outcomes were selected as the most relevant primary outcome 
measures in the present study. In paper I, the ODI change, defined as the baseline ODI minus 
the ODI at the one-year follow-up, was chosen as the primary outcome measure and VAS for 
leg pain and LBP were chosen as secondary outcome measures. A higher value for ODI 
change indicated a more favourable functional outcome. In paper II, the outcome measures 
were the VAS leg pain and PPT for the gluteal muscles. In paper III, the outcome measures 
were the McGill sensory score and the VAS score for  LBP.  In  paper  IV,  the  outcome  
measures  were  VAS  activity  score, McGill sensory score, and ODI. 
 
3.4. MRI (paper I and III) 
Baseline lumbar MRI (1.5 T in 86% of the cases, 1.0 T in 12%, unknown or 3.0 T in 2%) was 
performed as part of clinical practice and included sagittal T2- and T1-weighted images and 
axial images of the L3/L4, L4/L5 and L5/S1 levels. All MRIs were de-identified and 
presented in random order. An experienced radiologist and a physical medicine and 
rehabilitation physician, independently and blinded to clinical data, graded MCs [126] and 
DD. DD is related to Modic changes [10] and was used as a covariate in the analyses. At each 
of the 10 EPs of L1–S1, we noted MCs as primary type I (hypointense signals on T1-weighted 
images and hyperintense signals on T2- weighted images), type II (hyperintense signals on 
T1-weighted images and iso/hyperintense signals on T2-weighted images), or type III 
(hypointense signals on both T1- and T2-weighted images). We graded the craniocaudal (CC) 
size of the MCs as <10%, 10%–25%, ≥ 25%–50%, or >50% of the vertebral body height [81]. 
In the final analyses, the first two CC size categories received a score of 0, and the subsequent 
categories received scores of 1, 2, and 3, respectively. A total CC size score for the 10 
endplates was calculated (possible values 0-30). 
 
DD was graded on midsagittal T2-weighted images at each of the five disc levels (L1–S1) 
using Schneiderman’s grading system [151]: a score of 0 indicated no signal change, a score 
of 1 indicated a slight decrease in signal intensity in the NP, a score of 2 indicated a 
generalized hypointense nucleus, and a score of 3 indicated a hypointense nucleus with disc 
space narrowing. The total DD score (0–15) across all five discs was calculated and then 
grouped according to Jim [82] into severe (two or more grade 3 discs, three or more grade 2 
discs, or one grade 3 and two grade 2 discs), moderate (one grade 3 disc or two grade 2 
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discs), mild (only one grade 2 disc and no grade 3 discs), or normal (total DD score of 0 or 1). 
In all cases of disagreement, a consensus score was negotiated. The independent evaluations 
showed mostly good interobserver agreement on type and CC size of MCs at EPs with at least 
10% prevalence of MCs (L2–S1), and thus interpretable kappa values (unweighted kappa for 
Modic type and linearly weighted kappa for Modic CC size, paper III) [154]. At levels with at 
least 10% prevalence of a DD score of 2 and 3 (also L2–S1), the interobserver agreement on 
DD was moderate or good (linearly weighted kappa for DD) (paper III). 
 
3.5. ELISA measurements of serum cytokine concentration (paper I) 
Blood samples were drawn during the initial screening visit at the hospital. A few patients, 
who had to wait for surgery longer than 8 weeks, were re-included with new blood samples. 
The serum analysis of the blood samples was performed at the National Institute of 
Occupational Health, Oslo. Laboratory method: After being on ice for 45 minutes, blood 
samples were centrifuged for 10 minutes at 40C and 2000 G. Further, serum was stored in 
duplicate at -800C until use. The serum concentrations of the two pro-inflammatory cytokines 
IL-6 and IL-8 were determined using commercial enzyme-linked immunosorbent assays 
(ELISA) kits according to the manufacturer’s instructions (human ultrasensitive kits for IL-6 
and IL-8, Invitrogen Corporation, CA, USA). Briefly, 100 μl of serum or IL-6 or IL-8 
standard was added to each well in microtitre plates pre-coated with an antibody specific for 
each cytokine, and then plates were incubated at room temperature. After washing the plates, 
100 μl of biotinylated antibody specific for IL-6 or IL-8 was added, and then plates  were  
incubated  at  room  temperature.  After  removal  of  excess secondary antibody by  washing,  
100  μl  of  streptavidin-conjugated horseradish peroxidase enzyme solution was added to 
each well. After incubating the plates at room temperature and washing the plates to remove 
all unbound enzyme, a substrate solution with chromogen was added to produce colour. The 
reaction was stopped by adding 100 μl of stop solution. The optical density was measured at a 
wavelength of 450 nm using a Fusion Universal Microplate analyser (Packard Instrument 
Company, Meriden, CT, USA). Data were analysed using the Fusion data analysis software 
program (Packard Instrument Company). The amount of IL-6 and IL-8 in all samples was  
quantified  based  on  a  standard  curve  prepared  for  each  analysed cytokine. Background 
absorbance was subtracted from all data points including the unknown samples and standards. 
Serum collected at three different time points for each patient was analysed on the same 
microtitre plate. Serum IL-6 was measured in pg/ml. According to the manufacturer, the 
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minimum detectable dose of IL-6 and IL-8 was 0.15 pg/ml and 0.4 pg/ml, respectively.  
 
3.6. Single nucleotide polymorphism (SNP) genotyping (paper II and IV) 
Blood samples were drawn and genomic DNA was extracted from whole blood cells using the 
FlexiGene DNA isolation kit (Qiagen, Hilsen, Germany). SNP genotyping was carried out 
using predesigned TaqMan SNP genotyping assays for rs1800587 (Applied Biosystems, 
Foster City, CA, USA). Approximately 10 ng genomic DNA was amplified in a 5-μl reaction 
mixture in a 384-well plate containing 1 × TaqMan genotyping master mix (Applied 
Biosystems) and 1 × assay mix, the latter containing the respective primers and probes. The 
probes were labelled with the reporter dye FAM or VIC to distinguish between the two 
alleles. After initial denaturation and enzyme activation at 95°C for 10 min, the reaction 
mixture was subjected to 60  cycles  of  95°C  for  15  s  and  60°C  for  1  min.  The  
reactions  were performed using an ABI 7900HT sequence detection system. Negative 
controls containing water instead of DNA were included in every run. Genotypes were 
determined using SDS 2.2 software (Applied Biosystems). Approximately 10% of the 
samples were re-genotyped and the concordance rate was 100%. 
 
3.7. Ethics 
The study was conducted in accordance with the Helsinki Declaration. The Regional 
Committee for Medical Research Ethics and the Norwegian Social Science  Data  Services  
approved  the  study  protocol  (REK  number  S-07239b), and all participants gave written 
informed consent. 
 
3.8. Statistical analysis 
All statistical analyses were performed using the statistical package PASW statistics 19 (paper 
I, II and III) and 18 (paper IV) (SPSS Inc., Chicago, IL, USA). Parametric statistical analyses 
based on the normally distributed data were performed. In paper I linear regression analysis 
was conducted; in paper II and IV repeated measures analysis of variance (rmANOVA) and 
one-way ANOVA were performed; and in paper III two-way and one-way ANOVAs were 
used to analyse the data. A p value <0.05 was chosen as the level  of  statistical  significance  
in  paper  I,  II,  and  IV.  In  paper  III  a Bonferroni correction was applied to adjust for 
multiple comparisons and a p-value of ≤0.013 (p ≤ 0.05/4) was regarded as statistically 
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significant. Covariates (age, sex, smoking, and treatment) were used in all analyses. In 
addition, DD grouped by Jim [82] and duration of lumbar radicular pain were used as 
covariates in paper III. 
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4. Main results           
  
4.1. Paper I 
Less favourable ODI outcome correlated with higher serum IL-6 levels (B =-3.41, 95% CI -
5.52 to -1.30, p = 0.002), non-surgical treatment (B = -7.03, 95% CI 1.21 to 12.84, p = 0.018), 
higher baseline back pain intensity (B =-2.28, 95% CI -3.21 to -1.35, p < 0.001), and low 
educational level (B = -5.57, 95% CI 0.66 to 10.47, p = 0.027). High VAS for LBP and leg 
pain at one year  was  associated  with  high  levels  of  serum  IL-6,  higher  back  pain 
intensity, and longer duration of lumbar radicular pain at baseline. 
 
4.2. Paper II 
The  IL-1α  gene  C>T  polymorphism  rs1800587  affected  VAS  and  PPT scores in patients 
with symptomatic DH. Patients with the CT/TT genotype reported a higher VAS leg pain 
intensity (p = 0.002) and a lower PPT in the gluteal muscles (left p = 0.016; right p = 0.016) 
compared with patients with the CC genotype during the 1-year follow-up period. 
 
4.3. Paper III 
Pain scores had decreased significantly at 12 months follow-up. Modic type showed a 
significant impact on McGill sensory score at 6 weeks (p = 0.007), but not at other time points 
or on VAS back pain or VAS leg pain scores. At 6 weeks, the mean McGill sensory score was 
higher in Modic I than in Modic II-III patients (p = 0.003) and in patients without Modic 
changes (p =0.018). Dichotomized Modic size L1-S1 had no impact on McGill sensory, back 
pain, or leg pain scores. 
  
4.4. Paper IV 
The data revealed a significant interaction between sex and A118G genotype regarding the 
pain intensity during the 12-month follow-up (VAS, p = 0.002; McGill, p = 0.021; ODI, p = 
0.205, repeated-measures ANOVA). We found that */G women had a slower recovery rate 
compared with */G men. Additionally, the */G women had 2.3 × as much pain as the */G men 
12 months after DH (VAS, p = 0.043, one-way ANOVA; p = 0.035, Tukey HSD). In contrast, 
the A/A women and A/A men had mostly equivalent recovery rates. 
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5. Discussion           
 
The fact that inflammation contributes to the pathogenesis of DH and radicular pain is now 
well established [128]. Therefore, proinflammatory cytokines, specifically ILs and TNF-α, are 
potential biomarkers of DD and DH [191]. The inflammatory response, initiated from the AF 
in case of DH [152], may lead to increased levels of pro-inflammatory cytokines close to 
nerve roots. This process may also be accompanied by new innervation and vascularization of 
discs after DH. In addition, ILs can drive inflammation through its secretion by myeloid cells 
[186]. However, the potential impact of cytokines in recovery after symptomatic DH is not 
fully understood. Our data showed an association between serum IL-6 levels and recovery of 
patients with lumbar radicular pain after DH. In addition to high initial back pain   intensity,   
non-surgical   treatment,   lower   educational   level,   and prolonged history of lumbar 
radicular pain prior to treatment, high IL-6 levels had a negative impact on the long-term 
recovery rate of patients with symptomatic DH. This demonstrates that intense pain and high 
levels of inflammatory cytokines such as IL-6 are risk factors for long-term disability in 
patients with lumbar radicular pain. Our findings support the concept that pro-inflammatory 
cytokines may promote radicular pain [39]. In addition to producing inflammation and 
inducing the synthesis of several nociceptor sensitizers, the pro-inflammatory cytokine IL-1 
rapidly and directly activates nociceptors to generate action potentials and induce pain 
hypersensitivity [19]. An increased release of IL-1β can then lead to an increase in the levels 
of other cytokines including IL-6 [87]. 
 
An association between serum IL-6 concentration at baseline and long-term disability in 
lumbar radicular pain may have an impact on treatment and selection for DH surgery. 
However, the population in our study was too small to examine the effects of IL-6 separately 
in patients who received surgery compared with those managed conservatively. Regarding 
treatment of lumbar radicular pain, more clinical research is necessary to determine the 
clinical results of anti-inflammatory therapy. In the last few years, epidural steroid injections 
have become increasingly popular worldwide. In a recent meta-analysis, it was found high-
quality evidence showing that epidural corticosteroid injections have small, short-term effects 
on leg pain and disability compared with placebo in patients with lumbar radicular pain, but 
no effect on the long-term [39, 144]. The use of TNF-α inhibitors administrated in the 
epidural space has also been tested in clinical trials and demonstrated controversial effects at 
the short-term follow-up [39]. Still, an enhanced understanding of the role of cytokines to 
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radicular pain due to DH, could provide new targets for the treatment of symptomatic DH and 
DD [147] and may be investigated in future studies. 
 
Cytokine release may be influenced by genetics factors. According to the central dogma of 
molecular biology, DNA encodes RNA, which in turn encodes the amino acid sequence of 
proteins by translation.  First, RNA is synthesized   from   the   DNA   template   through   a   
process   known   as transcription. The RNA, carrying the coded information in a form called 
messenger RNA (mRNA), is then transported from the cell nucleus to the cytoplasm, where 
the RNA sequence is decoded, or translated, to determine the sequence of amino acids in the 
protein being synthesized. The process of translation occurs on ribosomes, involving transfer 
RNA (tRNA). Hence, the flow of information from gene to protein involves several steps 
where each step is potential subject to error, leading to mutations or polymorphisms. Patients  
with  polymorphism  of  inflammatory  genes,  for  example  IL-1α (rs1800587) T genotype 
have enhanced IL-α level, resulting in a more pronounced  inflammatory  response  [44].  Our  
data  show  that  the  IL-1α CT/TT genotype may be associated with increased leg pain 
intensity, as well as a decreased PPT during the first year after DH. These findings may help 
explain more leg pain, but also a more generalized decrease in the pain threshold during the 
first year after DH among patients with the T allele. Thus, the present data show that genetic 
variation in the gene encoding IL-1α may be crucial for the PPT, often used clinically to 
predict clinical outcome. 
 
IL-1α is a very strong inducer of inflammation, and causes a broad spectrum of  changes  in  
neurological,  metabolic,  haematological,  and  endocrine systems  [157].  Thus,  the  IL-1α  
C>T  genotype  may  be  associated  with several undesirable characteristics of the pain 
pathways. For example, IL-1α alters substance P and nerve growth factor expression via the 
IL-1 receptor [155], which could possibly increase spinal nociceptive signaling. Taken 
together, this emphasizes the important functional role of IL1, which may also be relevant for 
future treatment decisions. Recent clinical data suggest that the recombinant form of the 
naturally occurring IL-1 receptor antagonist (IL1RN) may be useful in the clinical 
management of inflammation. The polymorphism of the IL1RN suppresses inflammatory 
reactions and clinical symptoms caused by IL1, which would make DH patient’s response to 
conservative treatment different [94]. An attempt to use gene therapy with IL1RN adenovirus 
transfection has also been performed in patients with rheumatoid arthritis or degenerative 
arthropathy, suggesting that genetic polymorphism of IL1RN affects clinical features of these 
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diseases [106]. However, whether patients carrying the IL-1α T allele may show enhanced 
effects of IL1RN, or other pharmacological therapies, remains to be investigated. 
  
The inflammatory process close to the disc after DH also increase the risk for MC (especially 
type I) during the following year [7]. Apparently, type I MCs represents acute stages of 
inflammation and is strongly associated with LBP [7]. Our results also demonstrated that 
patients with type I MCs had a significantly higher McGill sensory pain score at 6 weeks, 
compared with patients with other Modic types or without MCs. This indicates slower 
recovery after DH among patients with type I MCs, perhaps due to inflammatory pain 
associated with I MCs [14, 47, 131]. Previous studies have shown an increased frequency of 
type I MCs in individuals with LBP [7, 102]. Here, we have extended these findings and 
demonstrated that type I MCs also influence the recovery in lumbar radicular pain. The 
increased sensory  pain  in  patients  with  type  I  MCs  is  clinically  important.  For example, 
patients with Modic type I may be informed that recovery may take more than 6 weeks, but 
that their prognosis is still good. In addition, it may be favorable with longer follow-up of 
these patients. 
 
Prevalence of MCs in our study was more that 70%, and more than 60% patients had MCs 
with a CC size of at least 10% of the vertebral height, which is a higher prevalence than that 
found among patients with lumbar DH in a previous study (range, 20%–49%) [7]. This can be 
partly explained by the characteristics of our study population: there is a higher prevalence of 
MCs among patients with chronic lumbar radicular pain versus those with acute or a 
combination of both types of lumbar radicular pain [7]. Similarly, the prevalence of MCs is 
higher among patients with chronic versus acute LBP [12, 27]. Recruitment from university 
hospitals may favor a high prevalence of MCs because of the higher prevalence of patients 
with chronic lumbar radicular pain. 
  
A substantial pain reduction was observed during the 12-month follow-up in these pain 
patients with and without MCs. However, patients with type I MCs  had  higher  sensory  pain  
scores  than  other  patients  at  6  weeks. Moreover, at 12 months, 31% of the patients in our 
study reported LBP and 25% reported leg pain, based on VAS scores > 3. These data are 
consistent with findings in the previous study where approximately 30% of the patients with 
symptomatic disc herniation had LBP that restricted work and leisure after 1 year [178]. 
Although most patients with radicular pain due to disc herniation have spontaneous regression 
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of symptoms [13, 178], such pain is associated with high consumption of health resources [23, 
100]. 
 
In the present work we also demonstrated an interaction between sex and the OPRM1 A118G 
genotype associated with recovery from LBP and sciatica. Specifically, women with the */G 
genotype reported more pain compared with the */G men 12 months after DH. Hence, our 
study supports the earlier observation that female patients with sciatica may have a slower 
recovery and a poorer 1-year outcome compared with male patients [143]. However, here we 
have extended these findings and demonstrated that pain is also related to a sex-specific 
genetic factor. Specifically, women carrying the 118G allele had a mean VAS activity pain 
score 2.3 × higher than men with the same genotype 12 months after LDH. This finding 
strongly support the hypothesis that the OPRM1 118G allele may influence the endogenous 
pain modulatory system differently depending on sex, which may be relevant for 
understanding  the  mechanisms  underlying  the  development  of  persistent LBP and 
radicular pain due to DH. Recent study has shown that combined genotype of CYP3A4*18B 
and OPRM1 A118G may influence postoperative effect of fentanyl [112]. According to the 
another study, the OPRM1 A118G SNP is a key contributor for the inter-individual variability 
in opioidrequirements in cancer pain patients [59]. 
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6. Conclusion           
 
- High levels of serum IL-6, but not DD or MCs, were associated with less favourable 
recovery in patients with lumbar radicular pain. Intense initial  back  pain,  
conservative  management,  lower educational level, and an extended duration of 
radicular pain before treatment were also associated with a slower recovery at 12 
months. This suggests that serum IL-6 level is a valid predictor of recovery in lumbar 
radicular pain. 
 
- The  IL-1α  CT/TT  genotype  rs1800587  may  be  associated  with increased pain 
intensity, and corresponding reduced PPT during the first year after DH. Thus, these 
data show that the IL-1α T genotype may  affect  clinical  outcome,  but  may  also  
affect  the  results  of clinical tests of patients suffering from lumbar radicular pain. 
 
- Most patients with lumbar radicular pain treated surgically and non- surgically can 
expect a substantial reduction in back and leg pain during the first year. Patients with 
Modic type I changes may, however,  have  a  slower  decrease  in  McGill  sensory  
pain  score and recovery in lumbar radicular pain than other patients. Neither the type 
nor the size of Modic changes seems to influence on McGill sensory pain, VAS back 
pain, or VAS leg pain scores at one-year follow-up. 
 
- The OPRM1 118G allele rs1799971 is associated with increased pain intensity in 
women, but reduced pain intensity in men in the first 12 months after a DH. An 
interaction between sex and the OPRM1 A118G genotype is associated with recovery 
of LBP and lumbar radicular pain due to DH. This suggests that the OPRM1 118G 
allele may influence the endogenous pain modulatory system differently depending  on  
sex,  and  contribute  to  the  high  VAS activity in women with symptomatic DH. 
 
 
 
 
 
 
 48 
 
7. References           
 
1.  Adams MA, Burton AK, Dolan P, Bogduk N (2007) The biomechanics of back pain. 
Churchill Livingstone 
2.  Adams MA, McNally DS, Dolan P (1996) 'Stress' distributions inside intervertebral discs.     
The effects of age and degeneration. J Bone Joint Surg Br 78:965-972 
3.  Adams MA, Roughley PJ (2006) What is intervertebral disc degeneration, and what causes 
it? Spine (Phila Pa 1976) 31:2151-2161 
4. Ahmad Omair (2013) Genetic predisposition to low back pain and lumbar disc 
degeneration. Doctoral Thesis. Faculty of Medicine, University of Oslo. 
5. Ahn SH, Cho YW, Ahn MW, Jang SH, Sohn YK, Kim HS (2002) mRNA expression of 
cytokines and chemokines in herniated lumbar intervertebral discs. Spine (Phila Pa 1976) 
27:911-917 
6. Albert HB, Kjaer P, Jensen TS, Sorensen JS, Bendix T, Manniche C (2008) Modic 
changes, possible causes and relation to low back pain. Med Hypotheses 70:361-368 
7. Albert HB, Manniche C (2007) Modic changes following lumbar disc herniation. Eur 
Spine J 16:977-982 
8.  Albert HB, Sorensen JS, Christensen BS, Manniche C (2013) Antibiotic treatment in   
patients with chronic low back pain and vertebral bone edema (Modic type 1 changes): a   
double-blind randomized clinical controlled trial of efficacy. Eur Spine J 22:697-707 
9.    Aminov RI (2013) Biotic acts of antibiotics. Front Microbiol 4:241 
10. Arana E, Kovacs FM, Royuela A, Estremera A, Asenjo B, Sarasibar H, Amengual G, 
Galarraga I, Alonso A, Casillas C, Muriel A, Montoya J, Ordonez C, Martinez C, Zamora 
J, Campillo C, Abraira V (2011) Modic changes and associated features in Southern 
European chronic low back pain patients. Spine J 11:402-411 
11. Arner EC, Hughes CE, Decicco CP, Caterson B, Tortorella MD (1998) Cytokine-induced 
cartilage proteoglycan degradation is mediated by aggrecanase. Osteoarthritis Cartilage 
6:214-228 
12. Ashworth J, Konstantinou K, Dunn KM (2011) Prognostic factors in non-surgically 
treated sciatica: a systematic review. BMC Musculoskelet Disord 12:208 
13.  Autio RA, Karppinen J, Niinimaki J, Ojala R, Kurunlahti M, Haapea M, Vanharanta H, 
Tervonen O (2006) Determinants of spontaneous resorption of intervertebral disc 
herniations. Spine (Phila Pa 1976)31:1247-1252 
 49 
 
 
14.  Bailly F, Maigne JY, Genevay S, Marty M, Gandjbakhch F, Rozenberg S, Foltz V (2013) 
Inflammatory pain pattern and pain with lumbar extension associated with Modic 1 
changes on MRI: a prospective case-control study of 120 patients. Eur Spine J 
15. Battie MC, Videman T, Gibbons LE, Fisher LD, Manninen H, Gill K (1995) 1995 Volvo 
Award in clinical sciences. Determinants of lumbar disc degeneration. A study relating 
lifetime exposures and magnetic resonance imaging findings in identical twins. Spine 
(Phila Pa 1976) 20:2601-2612 
16. Battie MC, Videman T, Kaprio J, Gibbons LE, Gill K, Manninen H, Saarela J, Peltonen 
L (2009) The Twin Spine Study: contributions to a changing view of disc degeneration. 
Spine J 9:47-59 
17.   Benarroch EE (2008) Descending monoaminergic pain modulation: bidirectional 
        control and clinical relevance. Neurology 71:217-221 
18. Berg L, Hellum C, Gjertsen O, Neckelmann G, Johnsen LG, Storheim K, Brox JI, Eide 
GE, Espeland A (2013) Do more MRI findings imply worse disability or more intense 
low back pain? A cross-sectional study of candidates for lumbar disc prosthesis. Skeletal 
Radiol 42:1593-1602 
19.  Binshtok AM, Wang H, Zimmermann K, Amaya F, Vardeh D, Shi L, Brenner GJ, Ji RR, 
Bean BP, Woolf CJ, Samad TA (2008) Nociceptors are interleukin-1beta sensors. J 
Neurosci 28:14062-14073 
20. Birkenmaier C (2013) Should We Start Treating Chronic Low Back Pain with Antibiotics 
Rather than with Pain Medications? Korean J Pain 26:327-335 
21.  Bogduk N (2009) On the definitions and physiology of back pain, referred pain, and 
radicular pain. Pain 147:17-19 
22.   Bogduk N (2005) Clinical anatomy of the lumbar spine and sacrum. Elsevier Churchill 
        Livingstone, Edinburgh 
23.  Brage S, Ihlebaek C, Natvig B, Bruusgaard D (2010) Musculoskeletal disorders as causes 
of sick leave and disability benefits. Tidsskr Nor Laegeforen 130:2369-2370 
24. Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D (2006) Survey of chronic 
pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain 10:287-333 
25. Brisby H (2006) Pathology and possible mechanisms of nervous system response to disc 
degeneration. J Bone Joint Surg Am 88 Suppl 2:68-71 
26. Brisby H, Byrod G, Olmarker K, Miller VM, Aoki Y, Rydevik B (2000) Nitric oxide as a 
mediator of nucleus pulposus-induced effects on spinal nerve roots. J Orthop Res 18:815-
 50 
 
820 
27. Brisby H, Olmarker K, Larsson K, Nutu M, Rydevik B (2002) Proinflammatory 
cytokines in cerebrospinal fluid and serum in patients with disc herniation and sciatica. 
Eur Spine J 11:62-66 
28. Carricajo A, Nuti C, Aubert E, Hatem O, Fonsale N, Mallaval FO, Vautrin AC, Brunon J, 
Aubert G (2007) Propionibacterium acnes contamination in lumbar disc surgery. J Hosp 
Infect 66:275-277 
29. Chataigner H, Onimus M, Polette A (1998) Surgery for degenerative lumbar disc  disease. 
Should the black disc be grafted? Rev Chir Orthop Reparatrice Appar Mot 84:583-589 
30. Chibnall JT, Tait RC (2009) Long-term adjustment to work-related low back pain: 
associations with socio-demographics, claim processes, and post-settlement adjustment. 
Pain Med 10:1378-1388 
31.  Chou D, Samartzis D, Bellabarba C, Patel A, Luk KD, Kisser JM, Skelly AC (2011) 
Degenerative magnetic resonance imaging changes in patients with chronic low back 
pain: a systematic review. Spine (Phila Pa 1976) 36:S43-S53 
32. Costello RF, Beall DP (2007) Nomenclature and standard reporting terminology of 
intervertebral disk herniation. Magn Reson Imaging Clin N Am 15:167-1vi 
33.  Dai F, Belfer I, Schwartz CE, Banco R, Martha JF, Tighioughart H, Tromanhauser SG, 
Jenis LG, Kim DH (2010) Association of catechol-O-methyltransferase genetic variants 
with outcome in patients undergoing surgical treatment for lumbar degenerative disc 
disease. Spine J 10:949-957 
34. de Roos A, Kressel H, Spritzer C, Dalinka M (1987) MR imaging of marrow changes 
adjacent to end plates in degenerative lumbar disk disease. AJR Am J Roentgenol 
149:531-534 
35. den Boer JJ, Oostendorp RA, Beems T, Munneke M, Oerlemans M, Evers AW (2006) A 
systematic review of bio-psychosocial risk factors for an unfavourable outcome after 
lumbar disc surgery. Eur Spine J 15:527-536 
36. Derogatis LR, Lipman RS, Rickels K, Uhlenhuth EH, Covi L (1974) The Hopkins 
Symptom Checklist (HSCL): a self-report symptom inventory. Behav Sci 19:1-15 
37.  Deville WL, van der Windt DA, Dzaferagic A, Bezemer PD, Bouter LM (2000) The test 
of Lasegue: systematic review of the accuracy in diagnosing herniated discs. Spine (Phila 
Pa 1976) 25:1140-1147 
38.  Deyo RA, Tsui-Wu YJ (1987) Functional disability due to back pain. A population-based 
       study indicating the importance of socioeconomic factors. Arthritis Rheum 30:1247-1253 
 51 
 
 
39.  Di Martino A, Merlini L, Faldini C (2013) Autoimmunity in intervertebral disc 
herniation: from bench to bedside. Expert Opin Ther Targets 17:1461-1470 
40.   Edwards RR, Klick B, Buenaver L, Max MB, Haythornthwaite JA, Keller RB, Atlas SJ 
(2007) Symptoms of distress as prospective predictors of pain-related sciatica treatment 
outcomes. Pain 130:47-55 
41. Egeland NG, Moen A, Pedersen LM, Brisby H, Gjerstad J (2013) Spinal nociceptive 
hyperexcitability induced by experimental disc herniation is associated with enhanced 
local expression of Csf1 and FasL. Pain 154:1743-1748 
42.  Emch TM, Modic MT (2011) Imaging of lumbar degenerative disk disease: history and 
current state. Skeletal Radiol 40:1175-1189 
43. Eskola PJ, Kjaer P, Daavittila IM, Solovieva S, Okuloff A, Sorensen JS, Wedderkopp N, 
Ala-Kokko L, Mannikko M, Karppinen JI (2010) Genetic risk factors of disc 
degeneration among 12-14-year-old Danish children: a population study. Int J Mol 
Epidemiol Genet 1:158-165 
44.  Eskola PJ, Kjaer P, Sorensen JS, Okuloff A, Wedderkopp N, Daavittila I, Ala-Kokko L, 
Mannikko M, Karppinen J (2012) Gender difference in genetic association between IL1A 
variant and early lumbar disc degeneration: a three-year follow-up. Int J Mol Epidemiol 
Genet 3:195-204 
45. Eskola PJ, Lemmela S, Kjaer P, Solovieva S, Mannikko M, Tommerup N, Lind-Thomsen 
A, Husgafvel-Pursiainen K, Cheung KM, Chan D, Samartzis D, Karppinen J (2012) 
Genetic association studies in lumbar disc degeneration: a systematic review. PLoS 
One7:e49995 
46. Fardon DF (2001) Nomenclature and classification of lumbar disc pathology. Spine 
(Phila Pa 1976 ) 26:461-462 
47. Fayad F, Lefevre-Colau MM, Rannou F, Quintero N, Nys A, Mace Y, Poiraudeau S, 
Drape JL, Revel M (2007) Relation of inflammatory modic changes to intradiscal steroid 
injection outcome in chronic low back pain. Eur Spine J 16:925-931 
48. Feng H, Danfelter M, Stromqvist B, Heinegard D (2006) Extracellular matrix in disc 
degeneration. J Bone Joint Surg Am 88 Suppl 2:25-29 
49.  Fields AJ, Liebenberg EC, Lotz JC (2013) Innervation of pathologies in the lumbar 
vertebral end plate and intervertebral disc. Spine J 
50. Fields HL, Heinricher MM, Mason P (1991) Neurotransmitters in nociceptive modulatory 
circuits. Annu Rev Neurosci 14:219-245 
 52 
 
 
51. Finskas O, Blixt A, Fujioka Y, Olmarker K (2013) New, Clinically more Relevant Model 
for Nerve Root Injury in the Rat. Spine (Phila Pa 1976) 38:1744-1748 
52. Fortin M, Macedo LG (2013) Multifidus and paraspinal muscle group cross-sectional 
areas of patients with low back pain and control patients: a systematic review with a 
focus on blinding. Phys Ther 93:873-888 
53. Franson RC, Saal JS, Saal JA (1992) Human disc phospholipase A2 is inflammatory. 
Spine (Phila Pa 1976) 17:S129-S132 
54.  Frino J, McCarthy RE, Sparks CY, McCullough FL (2006) Trends in adolescent lumbar 
disk herniation. J Pediatr Orthop 26:579-581 
55. Gao X, Zhang Y, Wu G (2000) Effects of dopaminergic agents on carrageenan 
hyperalgesia in rats. Eur J Pharmacol 406:53-58 
56. Gerber RK, Nie H, Arendt-Nielsen L, Curatolo M, Graven-Nielsen T (2011) Local pain 
and spreading hyperalgesia induced by intramuscular injection of nerve growth factor are 
not reduced by local anesthesia of the muscle. Clin J Pain 27:240-247 
57. Gibson JN, Grant IC, Waddell G (1999) The Cochrane review of surgery for lumbar disc 
prolapse and degenerative lumbar spondylosis. Spine (Phila Pa 1976) 24:1820-1832 
58.  Gjerstad J (2007) Genetic susceptibility and development of chronic non-malignant back 
pain. Rev Neurosci 18:83-91 
59.  Gong XD, Wang JY, Liu F, Yuan HH, Zhang WY, Guo YH, Jiang B (2013) Gene 
Polymorphisms of OPRM1 A118G and ABCB1 C3435T May Influence Opioid 
Requirements in Chinese Patients with Cancer Pain. Asian Pac J Cancer Prev 14:2937-
2943 
60. Gopal D, Ho AL, Shah A, Chi JH (2012) Molecular basis of intervertebral disc 
degeneration. Adv Exp Med Biol 760:114-133 
61.  Gottesman II, Gould TD (2003) The endophenotype concept in psychiatry: etymology 
and strategic intentions. Am J Psychiatry 160:636-645 
62.  Goupille P, Jayson MI, Valat JP, Freemont AJ (1998) Matrix metalloproteinases: the clue 
to intervertebral disc degeneration? Spine (Phila Pa 1976) 23:1612-1626 
63. Gronblad M, Virri J, Tolonen J, Seitsalo S, Kaapa E, Kankare J, Myllynen P, Karaharju 
EO (1994) A controlled immunohistochemical study of inflammatory cells in disc 
herniation tissue. Spine (Phila Pa 1976) 19:2744-2751 
64.  Grotle M, Brox JI, Vollestad NK (2003) Cross-cultural adaptation of the Norwegian 
versions of the Roland-Morris Disability Questionnaire and the Oswestry Disability 
 53 
 
Index. J Rehabil Med 35:241-247 
65. Habtemariam A, Gronblad M, Virri J, Seitsalo S, Karaharju E (1998) A comparative 
immunohistochemical study of inflammatory cells in acute-stage and chronic-stage disc 
herniations. Spine (Phila Pa 1976)23:2159-2165 
66. Habtemariam A, Gronblad M, Virri J, Seitsalo S, Ruuskanen M, Karaharju E (1996) 
Immunocytochemical localization of immunoglobulins in disc herniations. Spine (Phila 
Pa 1976)21:1864-1869 
67.  Harry N.Herkowitz, International Society for Study of the Lumbar Spine (2004)  
       The Lumbar Spine. Lippincott Williams & Wilkins 
68. Hashizume H, Kawakami M, Nishi H, Tamaki T (1997) Histochemical demonstration of 
nitric oxide in herniated lumbar discs. A clinical and animal model study. Spine (Phila Pa 
1976)22:1080-1084 
69. Haugen AJ, Brox JI, Grovle L, Keller A, Natvig B, Soldal DM, Grotle M (2012) 
Prognostic factors for non-success in patients with sciatica and disc herniation. BMC 
Musculoskelet Disord 13:183 
70. Havemose-Poulsen A, Sorensen LK, Bendtzen K, Holmstrup P (2007) Polymorphisms 
within the IL-1 gene cluster: effects on cytokine profiles in peripheral blood and whole 
blood cell cultures of patients with aggressive periodontitis, juvenile idiopathic arthritis, 
and rheumatoid arthritis. J Periodontol 78:475-492 
71. Hellum C, Johnsen LG, Gjertsen O, Berg L, Neckelmann G, Grundnes O, Rossvoll I, 
Skouen JS, Brox JI, Storheim K (2012) Predictors of outcome after surgery with disc 
prosthesis and rehabilitation in patients with chronic low back pain and degenerative disc: 
2-year follow-up. Eur Spine J 21:681-690 
72.  Howe JF, Loeser JD, Calvin WH (1977) Mechanosensitivity of dorsal root ganglia and 
chronically injured axons: a physiological basis for the radicular pain of nerve root 
compression. Pain 3:25-41 
73. Hsu P.S., Armon C, Levin K (2011) Lumbosacral radiculopathy: Pathophysiology, 
clinical features, and diagnosis. Official reprint from UpToDate 
74.  Hutton MJ, Bayer JH, Powell JM (2011) Modic vertebral body   changes: the natural 
history as assessed by consecutive magnetic resonance imaging. Spine (Phila Pa 1976) 
36:2304-2307 
75. Igarashi T, Kikuchi S, Shubayev V, Myers RR (2000) 2000 Volvo Award winner in basic 
science studies: Exogenous tumor necrosis factor-alpha mimics nucleus pulposus-induced 
neuropathology. Molecular, histologic, and behavioral comparisons in rats. Spine (Phila 
 54 
 
Pa 1976) 25:2975-2980 
76. Ikeda T, Nakamura T, Kikuchi T, Umeda S, Senda H, Takagi K (1996) Pathomechanism 
of spontaneous regression of the herniated lumbar disc: histologic and 
immunohistochemical study. J Spinal Disord 9:136-140 
77. Ikegawa S (2013) The genetics of common degenerative skeletal disorders: osteoarthritis 
and degenerative disc disease. Annu Rev Genomics Hum Genet 14:245-256 
78. Ilmarinen J, Suurnakki T, Nygard CH, Landau K (1991) Classification of municipal 
occupations. Scand J Work Environ Health 17 Suppl 1:12-29 
79.  Jacobsen LM, Schistad EI, Storesund A, Pedersen LM, Rygh LJ, Roe C, Gjerstad J (2012) 
The COMT rs4680 Met allele contributes to long-lasting low back pain, sciatica and 
disability after lumbar disc herniation. Eur J Pain 16:1064-1069 
80. Jensen TS, Karppinen J, Sorensen JS, Niinimaki J, Leboeuf-Yde C (2008) Vertebral 
endplate signal changes (Modic change): a systematic literature review of prevalence and 
association with non- specific low back pain. Eur Spine J 17:1407-1422 
81. Jensen TS, Sorensen JS, Kjaer P (2007) Intra- and interobserver reproducibility of 
vertebral endplate signal (modic) changes in the lumbar spine: the Nordic Modic 
Consensus Group classification. Acta Radiol 48:748-754 
82.  Jim JJ, Noponen-Hietala N, Cheung KM, Ott J, Karppinen J, Sahraravand A, Luk KD, 
Yip SP, Sham PC, Song YQ, Leong JC, Cheah KS, Ala-Kokko L, Chan D (2005) The 
TRP2 allele of COL9A2 is an age-dependent risk factor for the development and severity 
of intervertebral disc degeneration. Spine (Phila Pa 1976)30:2735-2742 
83.   Julius D, Basbaum AI (2001) Molecular mechanisms of nociception. Nature 413:203-210 
84.  Jussila L, Paananen M, Nayha S, Taimela S, Tammelin T, Auvinen J, Karppinen J (2013) 
Psychosocial and lifestyle correlates of musculoskeletal pain patterns in adolescence: A 
2-year follow-up study. Eur J Pain 
85. Kalichman L, Hunter DJ (2008) The genetics of intervertebral disc degeneration. 
Associated genes. Joint Bone Spine 75:388-396 
86.  Kang JD, Georgescu HI, McIntyre-Larkin L, Stefanovic-Racic M, Donaldson WF, III, 
Evans CH (1996) Herniated lumbar intervertebral discs spontaneously produce matrix 
metalloproteinases, nitric oxide, interleukin-6, and prostaglandin E2. Spine (Phila Pa 
1976) 21:271-277 
87. Kang JD, Stefanovic-Racic M, McIntyre LA, Georgescu HI, Evans CH (1997) Toward a 
biochemical understanding of human intervertebral disc degeneration and herniation. 
Contributions of nitric oxide, interleukins, prostaglandin E2, and matrix 
 55 
 
metalloproteinases. Spine (Phila Pa 1976) 22:1065-1073 
88. Karppinen J, Daavittila I, Noponen N, Haapea M, Taimela S, Vanharanta H, Ala-Kokko 
L, Mannikko M (2008) Is the interleukin-6 haplotype a prognostic factor for sciatica? Eur 
J Pain 12:1018-1025 
89. Kawaguchi Y, Osada R, Kanamori M, Ishihara H, Ohmori K, Matsui H, Kimura T (1999) 
Association between an aggrecan gene polymorphism and lumbar disc degeneration. 
Spine (Phila Pa 1976)24:2456-2460 
90. Kawakami M, Matsumoto T, Kuribayashi K, Tamaki T (1999) mRNA expression of 
interleukins, phospholipase A2, and nitric oxide synthase in the nerve root and dorsal root 
ganglion induced by autologous nucleus pulposus in the rat. J Orthop Res 17:941-946 
91. Kawakami M, Tamaki T, Hayashi N, Hashizume H, Nishi H (1998) Possible mechanism 
of painful radiculopathy in lumbar disc herniation. Clin Orthop Relat Res241-251 
92. Kawakami M, Weinstein JN, Chatani K, Spratt KF, Meller ST, Gebhart GF (1994) 
Experimental lumbar radiculopathy. Behavioral and histologic changes in a model of 
radicular pain after spinal nerve root irritation with chromic gut ligatures in the rat. Spine 
(Phila Pa1976) 19:1795-1802 
93. Keller A, Boyle E, Skog TA, Cassidy JD, Bautz-Holter E (2012) Are Modic changes 
prognostic for recovery in a cohort of patients with non-specific low back pain? Eur 
Spine J 21:418-424 
94. Kim DH, Lee SH, Kim KT, Yu SD (2010) Association of interleukin-1 receptor 
antagonist gene polymorphism with response to conservative treatment of lumbar 
herniated nucleus pulposus. Spine (Phila Pa 1976) 35:1527-1531 
95. Kim WH, Lee SH, Lee DY (2011) Changes in the cross-sectional area of multifidus and 
psoas in unilateral sciatica caused by lumbar disc herniation. J Korean Neurosurg Soc   
50:201-204 
96. Kjaer P, Leboeuf-Yde C, Korsholm L, Sorensen JS, Bendix T (2005) Magnetic 
resonance imaging and low back pain in adults: a diagnostic imaging study of 40-year-
old men and women. Spine (Phila Pa 1976) 30:1173-1180 
97. Koes BW, van Tulder MW, Peul WC (2007) Diagnosis and treatment of sciatica. Br Med 
J 334:1313-1317 
98. Konstantinou K, Beardmore R, Dunn KM, Lewis M, Hider SL, Sanders T, Jowett S, 
Somerville S, Stynes S, van der Windt DA, Vogel S, Hay EM (2012) Clinical course, 
characteristics and prognostic indicators in patients presenting with back and leg pain in 
primary care. The ATLAS study protocol. BMC Musculoskelet Disord 13:4 
 56 
 
 
99. Konstantinou K, Dunn KM (2008) Sciatica: review of epidemiological studies and   
prevalence estimates. Spine (Phila Pa1976) 33:2464-2472 
100. Konstantinou K, Dunn KM (2008) Sciatica: review of epidemiological studies and 
prevalence estimates. Spine (Phila Pa1976) 33:2464-2472 
101. Kuisma M, Karppinen J, Niinimaki J, Kurunlahti M, Haapea M, Vanharanta H, 
Tervonen O (2006) A three-year follow-up of lumbar spine endplate (Modic) changes. 
Spine (Phila Pa 1976) 31:1714-1718 
102. Kuisma M, Karppinen J, Niinimaki J, Ojala R, Haapea M, Heliovaara M, Korpelainen 
R, Taimela S, Natri A, Tervonen O (2007) Modic changes in endplates of lumbar 
vertebral bodies: prevalence and association with low back and sciatic pain among 
middle-aged male workers. Spine (Phila Pa 1976) 32:1116-1122 
103. Kwon M, Altin M, Duenas H, Alev L (2013) The Role of Descending Inhibitory 
Pathways on Chronic Pain Modulation and Clinical Implications. Pain Pract 
104. Lapossy E, Maleitzke R, Hrycaj P, Mennet W, Muller W (1995) The frequency of 
transition of chronic low back pain to fibromyalgia. Scand J Rheumatol 24:29-33 
105. Le Maitre CL, Freemont AJ, Hoyland JA (2005) The role of interleukin-1 in the 
pathogenesis of human intervertebral disc degeneration. Arthritis Res Ther 7:R732-
R745 
106.  Le Maitre CL, Freemont AJ, Hoyland JA (2006) A preliminary in vitro study into the 
use of IL-1Ra gene therapy for the inhibition of intervertebral disc degeneration. Int J 
Exp Pathol 87:17-28 
107.  Le BD (2002) The whole body receptive field of dorsal horn multireceptive neurones. 
Brain Res Brain Res Rev 40:29-44 
108.  Le BD, Dickenson AH, Besson JM (1979) Diffuse noxious inhibitory controls (DNIC). 
I. Effects on dorsal horn convergent neurones in the rat. Pain 6:283-304 
109. Lee MC, Tracey I (2013) Imaging pain: a potent means for investigating pain 
mechanisms in patients. Br J Anaesth 111:64-72 
110.  Levin K., Hsu P.S., Armon C. (2013) Acute lumbosacral radiculopathy: Prognosis and 
treatment. UpToDate 
111. Lewis GN, Rice DA, McNair PJ (2012) Conditioned pain modulation in populations with 
chronic pain: a systematic review and meta-analysis. J Pain 13:936-944 
112.  Liao Q, Chen DJ, Zhang F, Li L, Hu R, Tang YZ, Ou-Yang W, Huang D (2013) Effect 
of CYP3A4*18B polymorphisms and interactions with OPRM1 A118G on 
 57 
 
postoperative fentanyl requirements in patients undergoing radical gastrectomy. Mol 
Med Rep 7:901-908 
113.   Loeser JD, Treede RD (2008) The Kyoto protocol of IASP Basic Pain Terminology. 
          Pain 137:473-477 
114. Lotsch J, Doehring A, Mogil JS, Arndt T, Geisslinger G, Ultsch (2013) Functional 
genomics of pain in analgesic drug development and therapy. Pharmacol Ther 139:60-
70 
 115. Lurie JD, Moses RA, Tosteson AN, Tosteson TD, Carragee EJ, Carrino JA, Kaiser JA, 
Herzog RJ (2013) Magnetic resonance imaging predictors of surgical outcome in 
patients with lumbar intervertebral disc herniation. Spine (Phila Pa 1976) 38:1216-1225 
116. Ma XL, Ma JX, Wang T, Tian P, Han C (2011) Possible role of autoimmune reaction in 
Modic Type I changes. Med Hypotheses 76:692-694 
117. Mannion AF, Elfering A (2006) Predictors of surgical outcome and their assessment. 
Eur Spine J 15 Suppl 1:S93-108 
118.  Marchand S (2012) The phenomenon of Pain. IASP Press Book 
119. Marchand S (2008) The physiology of pain mechanisms: from the periphery to the 
brain. Rheum Dis Clin North Am 34:285-309 
120. Mayer JE, Iatridis JC, Chan D, Qureshi SA, Gottesman O, Hecht AC (2013) Genetic 
polymorphisms associated with intervertebral disc degeneration. Spine J 13:299-317 
121. McLorinan GC, Glenn JV, McMullan MG, Patrick S (2005) Propionibacterium acnes 
wound contamination at the time of spinal surgery. Clin Orthop Relat Res67-73 
122. Melzack R, Wall PD, Ty TC (1982) Acute pain in an emergency clinic: latency of onset 
and descriptor patterns related to different injuries. Pain 14:33-43 
123. Merskey H, Bogduk N (2004) Classification of chronic pain: descriptions of chronic 
pain syndromes and descriptions of pain terms. IASP Press, Seattle 
124. Merskey H, Bogduk N, editors (1994) Classification of chronic pain. (WA): 
International Association for the Study of Pain; Seattle, p.394 
125.   Mixter W.J., Barr J.S. (1934) Rupture of the Intervertebral Disc with 
          Involvement of Spinal Canal. New Engl J Med 211:-215 
126. Modic MT, Steinberg PM, Ross JS, Masaryk TJ, Carter JR (1988) Degenerative disk 
disease: assessment of changes in vertebral body marrow with MR imaging. Radiology 
166:193-199 
127.   Moore RJ (2000) The vertebral end-plate: what do we know? Eur Spine J 9:92-96 
 
 58 
 
128. Mulleman D, Mammou S, Griffoul I, Watier H, Goupille P (2006) Pathophysiology of 
disk-related sciatica. I.--Evidence supporting a chemical component. Joint Bone Spine 
73:151-158 
129. Muller S, Thomas E, Dunn KM, Mallen CD (2013) A prognostic approach to defining 
chronic pain across a range of musculoskeletal pain sites. Clin J Pain 29:411-416 
130. Nygaard OP, Mellgren SI, Osterud B (1997) The inflammatory properties of contained 
and noncontained lumbar disc herniation. Spine (Phila Pa 1976) 22:2484-2488 
131. Ohtori S, Inoue G, Ito T, Koshi T, Ozawa T, Doya H, Saito T, Moriya H, Takahashi K 
(2006) Tumor necrosis factor- immunoreactive cells and PGP 9.5-immunoreactive nerve 
fibers in vertebral endplates of patients with discogenic low back Pain and Modic Type 
1 or Type 2 changes on MRI. Spine (Phila Pa 1976)31:1026-1031 
132. Ohtori S, Yamashita M, Yamauchi K, Inoue G, Koshi T, Suzuki M, Orita S, Eguchi Y, 
Ochiai N, Kishida S, Takaso M, Aoki Y, Ishikawa T, Arai G, Miyagi M, Kamoda H, 
Nakamura J, Takahashi K (2010) Low back pain after lumbar discectomy in patients 
showing endplate modic type 1 change. Spine (Phila Pa 1976) 35:E596-E600 
133. Olmarker K, Blomquist J, Stromberg J, Nannmark U, Thomsen P, Rydevik B (1995) 
Inflammatogenic properties of nucleus pulposus. Spine (Phila Pa 1976) 20:665-669 
134. Olmarker K, Rydevik B, Nordborg C (1993) Autologous nucleus pulposus induces 
neurophysiologic and histologic changes in porcine cauda equina nerve roots. Spine 
(Phila Pa 1976) 18:1425-1432 
135. Olmarker K, Storkson R, Berge OG (2002) Pathogenesis of sciatic pain: a study of 
spontaneous behavior in rats exposed to experimental disc herniation. Spine (Phila Pa 
1976) 27:1312-1317 
136. Olsen MB, Jacobsen LM, Schistad EI, Pedersen LM, Rygh LJ, Roe C, Gjerstad J (2012) 
Pain intensity the first year after lumbar disc herniation is associated with the A118G 
polymorphism in the opioid receptor mu 1 gene: evidence of a sex and genotype 
interaction. J Neurosci 32:9831-9834 
137.  Omair A, Holden M, Lie BA, Reikeras O, Brox JI (2013) Treatment outcome of chronic 
low back pain and radiographic lumbar disc degeneration are associated with 
inflammatory and matrix degrading gene variants: a prospective genetic association 
study. BMC Musculoskelet Disord 14:105 
138. Omair A, Lie BA, Reikeras O, Holden M, Brox JI (2012) Genetic contribution of 
catechol-O-methyltransferase variants in treatment outcome of low back pain: a 
prospective genetic association study. BMC Musculoskelet Disord 13:76 
 59 
 
 
139.  Omarker K, Myers RR (1998) Pathogenesis of sciatic pain: role of herniated nucleus 
pulposus and deformation of spinal nerve root and dorsal root ganglion. Pain 78:99-105 
140.  Ostelo RW, Vlaeyen JW, van den Brandt PA, de Vet HC (2005) Residual complaints 
following lumbar disc surgery: prognostic indicators of outcome. Pain 114:177-185 
141.  Paz AJ, Fernandez B, I, Lopez-Anglada FE, Montes AH, Paz AA, Pena VJ, Ramos GS, 
Anton GS, Lopez FP, Valle-Garay E, Asensi V (2011) The IL-1beta (+3953 T/C) gene 
polymorphism associates to symptomatic lumbar disc herniation. Eur Spine J 20 Suppl 
3:383-389 
142.  Pennisi E (2012) Genomics. ENCODE project writes eulogy for junk DNA. Science 
337:1159, 1161 
143.  Peul WC, Brand R, Thomeer RT, Koes BW (2008) Influence of gender and other 
prognostic factors on outcome of sciatica. Pain 138:180-191 
144. Pinto RZ, Maher CG, Ferreira ML, Hancock M, Oliveira VC, McLachlan AJ, Koes B, 
Ferreira PH (2012) Epidural corticosteroid injections in the management of sciatica: a 
systematic review and meta-analysis. Ann Intern Med 157:865-877 
145.   Rajasekaran S, Bajaj N, Tubaki V, Kanna RM, Shetty AP (2013) ISSLS Prize winner: 
The anatomy of failure in lumbar disc herniation: an in vivo, multimodal, prospective 
study of 181 subjects. Spine (Phila Pa 1976) 38:1491-1500 
146. Rhudy JL, DelVentura JL, Terry EL, Bartley EJ, Olech E, Palit S, Kerr KL (2013)   
Emotional modulation of pain and spinal nociception in fibromyalgia. Pain 154:1045-
1056 
147. Risbud MV, Shapiro IM (2013) Role of cytokines in intervertebral disc degeneration: 
pain and disc content. Nat Rev Rheumatol 
148. Sambrook PN, MacGregor AJ, Spector TD (1999) Genetic influences on cervical and 
lumbar disc degeneration: a magnetic resonance imaging study in twins. Arthritis 
Rheum 42:366-372 
149. Sandanger I, Nygard JF, Ingebrigtsen G, Sorensen T, Dalgard OS (1999) Prevalence, 
incidence and age at onset of psychiatric disorders in Norway. Soc Psychiatry Psychiatr 
Epidemiol 34:570-579 
150. Sarzi-Puttini P, Atzeni F, Mease PJ (2011) Chronic widespread pain: from peripheral to  
central evolution. Best Pract Res Clin Rheumatol 25:133-139 
151. Schneiderman G, Flannigan B, Kingston S, Thomas J, Dillin WH, Watkins RG (1987) 
Magnetic resonance imaging in the diagnosis of disc degeneration: correlation with 
 60 
 
discography. Spine (Phila Pa 1976) 12:276-281 
152. Schroeder M, Viezens L, Schaefer C, Friedrichs B, Algenstaedt P, Ruther W, Wiesner 
L, Hansen-Algenstaedt N (2013) Chemokine profile of disc degeneration with acute or 
chronic pain. J Neurosurg Spine 
153. Silveira JW, Dias QM, Del Bel EA, Prado WA (2010) Serotonin receptors are involved 
in the spinal mediation of descending facilitation of surgical incision-induced increase 
of Fos-like immunoreactivity in rats. Mol Pain 6:17 
154. Sim J, Wright CC (2005) The kappa statistic in reliability studies: use, interpretation, 
and sample size requirements. Phys Ther 85:257-268 
155. Skoff AM, Zhao C, Adler JE (2009) Interleukin-1alpha regulates substance P expression 
and release in adult sensory neurons. Exp Neurol 217:395-400 
156.  Smyth MJ, Wright V (1958) Sciatica and the intervertebral disc; an experimental study. 
J Bone Joint Surg Am 40-A:1401-1418 
157.  Solovieva S, Kouhia S, Leino-Arjas P, Ala-Kokko L, Luoma K, Raininko R, Saarela J, 
Riihimaki H (2004) Interleukin 1 polymorphisms and intervertebral disc degeneration. 
Epidemiology15:626-633 
158.  Sorlie A, Moholdt V, Kvistad KA, Nygaard OP, Ingebrigtsen T, Iversen T, Kloster R, 
Solberg TK (2012) Modic type I changes and recovery of back pain after lumbar 
microdiscectomy. Eur Spine J 21:2252-2258 
159.  Sotto A, Dupeyron A (2013) Letter to the editor concerning: "Antibiotic treatment in 
patients with chronic low back pain and vertebral bone edema (Modic type 1 changes): a 
double-blind randomized controlled trial of efficacy" by Albert HB et al. Eur Spine J 
(2013) 22:697-707. Eur Spine J 22:1704-1705 
160.  Spiliopoulou I, Korovessis P, Konstantinou D, Dimitracopoulos G (1994) IgG and IgM 
concentration in the prolapsed human intervertebral disc and sciatica etiology. Spine 
(Phila Pa 1976)19:1320-1323 
161. Stafford MA, Peng P, Hill DA (2007) Sciatica: a review of history, epidemiology, 
pathogenesis, and the role of epidural steroid injection in management. Br J Anaesth 
99:461-473 
162. Stirling A, Jiggins M (2002) Association between Sciatica and Skin Commensals. 
International Society for the Study of the Lumbar Spine, Cleveland, 
163.  Stirling A, Worthington T, Rafiq M, Lambert PA, Elliott TS (2001) Association between 
sciatica and Propionibacterium acnes. Lancet 357:2024-2025 
 
 61 
 
164.  Strand LI, Wisnes AR (1991) The development of a Norwegian pain questionnaire. Pain 
46:61-66 
165. Tomic S, Soldo-Butkovic S, Kovac B, Faj D, Juric S, Misevic S, Knezevic L, 
Vukasinovic D (2009) Lumbosacral radiculopathy-- factors effects on it's severity. Coll 
Antropol 33:175-178 
166.  Tracey I (2011) Can neuroimaging studies identify pain endophenotypes in humans? Nat 
Rev Neurol 7:173-181 
167. Tracey I, Mantyh PW (2007) The cerebral signature for pain perception and its 
modulation. Neuron 55:377-391 
168. Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, Griffin JW, Hansson P, 
Hughes R, Nurmikko T, Serra J (2008) Neuropathic pain: redefinition and a grading 
system for clinical and research purposes. Neurology 70:1630-1635 
169.  Urban JP, Roberts S (2003) Degeneration of the intervertebral disc. Arthritis Res Ther 
     5:120-130 
170. Vargas-Prada S, Martinez JM, Coggon D, Delclos G, Benavides FG, Serra C (2013) 
Health beliefs, low mood, and somatizing tendency: contribution to incidence and 
persistence of musculoskeletal pain with and without reported disability. Scand J Work 
Environ Health 39:589-598 
171. Videman T, Saarela J, Kaprio J, Nakki A, Levalahti E, Gill K, Peltonen L, Battie MC 
(2009) Associations of 25 structural, degradative, and inflammatory candidate genes 
with lumbar disc desiccation, bulging, and height narrowing. Arthritis Rheum 60:470-
481 
172. Vining R, Potocki E, Seidman M, Morgenthal AP (2013) An evidence-based diagnostic 
classification system for low back pain. J Can Chiropr Assoc 57:189-204 
173. Vredeveld T, Teitsma XM, Mert A, Van der Wurff P (2012) Prevalence of modic 
changes in active duty military men with lumbar disk herniation who were scheduled for 
surgery. J Manipulative Physiol Ther 35:622-628 
174. Vroomen PC, de Krom MC, Knottnerus JA (1999) Diagnostic value of history and 
physical examination in patients suspected of sciatica due to disc herniation: a 
systematic review. J Neurol 246:899-906 
175. Waddell G (1998) The epidemiology of low back pain. In: Waddell G, ed (eds) The 
back pain revolution. Churchill Livingstone, New York, pp 69-84 
176. Waddell G, Aylward M, Sawney P (2002) Back pain, incapacity for work and social 
security benefits: an international literature review and analysis. The Royal Society of 
 62 
 
Medicine Press, London 
177. Wannstrom I, Peterson U, Asberg M, Nygren A, Gustavsson JP (2009) Psychometric 
properties of scales in the General Nordic Questionnaire for Psychological and Social 
Factors at Work (QPS): confirmatory factor analysis and prediction of certified long-
term sickness absence. Scand J Psychol 50:231-244 
178. Weber H (1994) The natural history of disc herniation and the influence of intervention. 
Spine (Phila Pa 1976) 19:2234-2238, discussion 2233 
179. Weber H, Holme I, Amlie E (1993) The natural course of acute sciatica with nerve root 
symptoms in a double-blind placebo- controlled trial evaluating the effect of piroxicam. 
Spine (Phila Pa 1976) 18:1433-1438 
180. Wedderkopp N, Thomsen K, Manniche C, Kolmos HJ, Secher JT, Leboeuf YC (2009) 
No evidence for presence of bacteria in modic type I changes. Acta Radiol 50:65-70 
181.  Wei J, Pan X, Pei Z, Wang W, Qiu W, Shi Z, Xiao G (2012) The beta-lactam antibiotic, 
ceftriaxone, provides neuroprotective potential via anti-excitotoxicity and anti-
inflammation response in a rat model of traumatic brain injury. J Trauma Acute Care 
Surg 73:654-660 
182. Williams FM, Bansal AT, van Meurs JB, Bell JT, Meulenbelt I, Suri P, Rivadeneira F, 
Sambrook PN, Hofman A, Bierma-Zeinstra S, Menni C, Kloppenburg M, Slagboom PE, 
Hunter DJ, MacGregor AJ, Uitterlinden AG, Spector TD (2013) Novel genetic variants 
associated with lumbar disc degeneration in northern Europeans: a meta-analysis of 
4600 subjects. Ann Rheum Dis 72:1141-1148 
183. Williams FM, Popham M, Sambrook PN, Jones AF, Spector TD, MacGregor AJ (2011) 
Progression of lumbar disc degeneration over a decade: a heritability study. Ann Rheum 
Dis 70:1203-1207 
184. Woolf CJ (2004) Pain: moving from symptom control toward mechanism-specific 
pharmacologic management. Ann Intern Med 140:441-451 
185.  Yabuki S, Kikuchi S, Olmarker K, Myers RR (1998) Acute effects of nucleus pulposus 
on blood flow and endoneurial fluid pressure in rat dorsal root ganglia. Spine (Phila Pa 
1976) 23:2517-2523 
186. Yazdi AS, Drexler SK (2013) Regulation of interleukin 1alpha secretion by 
inflammasomes. Ann Rheum Dis 72 Suppl 2:ii96-ii99 
187. Yeung AT, Yeung CA (2006) In-vivo endoscopic visualization of patho-anatomy in 
painful degenerative conditions of the lumbar spine. Surg Technol Int 15:243-256 
 
 63 
 
188.  Yilmaz P, Diers M, Diener S, Rance M, Wessa M, Flor H (2010) Brain correlates of 
stress-induced analgesia. Pain 151:522-529 
189.  Younes M, Bejia I, Aguir Z, Letaief M, Hassen-Zrour S, Touzi M, Bergaoui N (2006) 
Prevalence and risk factors of disk-related sciatica in an urban population in Tunisia. 
Joint Bone Spine 73:538-542 
190.  Zeitz KP, Guy N, Malmberg AB, Dirajlal S, Martin WJ, Sun L, Bonhaus DW, Stucky 
CL, Julius D, Basbaum AI (2002) The 5-HT3 subtype of serotonin receptor contributes 
to nociceptive processing via a novel subset of myelinated and unmyelinated 
nociceptors. J Neurosci 22:1010-1019 
191.  Zhang Y, Chee A, Thonar EJ, An HS (2011) Intervertebral disk repair by protein, gene, 
or cell injection: a framework for rehabilitation-focused biologics in the spine. PM R 
3:S88-S94 
192. Zhang YG, Sun Z, Zhang Z, Liu J, Guo X (2009) Risk factors for lumbar intervertebral 
disc herniation in Chinese population: a case- control study. Spine (Phila Pa 1976) 
34:E918-E922 
193. Zhang YG, Zhang F, Sun Z, Guo W, Liu J, Liu M, Guo X (2013) A controlled case 
study of the relationship between environmental risk factors and apoptotic gene 
polymorphism and lumbar disc herniation. Am J Pathol 182:56-63 
194. Zubieta JK, Heitzeg MM, Smith YR, Bueller JA, Xu K, Xu Y, Koeppe RA, Stohler CS, 
Goldman D (2003) COMT val158met genotype affects mu-opioid neurotransmitter 
responses to a pain stressor. Science 299:1240-1243 
 
 
 
 
 
 
 
 
 
 
 
 
 
 64 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reprinted with permission from Elsevier Limited 
 
I 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IL-6 and recovery in lumbar radicular pain  
 
1 
 
Original article: 
 
Title: Association between baseline IL-6 and one-year recovery in lumbar 
radicular pain 
 
E.I. Schistad1,2*, A. Espeland3,4, L.M. Pedersen5,6, L. Sandvik7, J. Gjerstad5,8, C. Røe1,2 
 
Affiliations 
1Department of Physical Medicine and Rehabilitation, Oslo University Hospital, Ullevål, 
Norway 
2Faculty of Medicine, University of Oslo, Norway 
3Department of Radiology, Haukeland University Hospital, Norway 
4Department of Surgical Sciences, University of Bergen, Norway 
5National Institute of Occupational Health, Oslo, Norway 
6Communication and Research Unit for Musculoskeletal Disorders (FORMI), Oslo University 
Hospital, Ullevål, Norway 
7Unit of Biostatistics and Epidemiology, Oslo University Hospital, Ullevål, Norway 
8Department of Molecular Biosciences, University of Oslo, Norway 
 
 
*Corresponding author 
Elina Iordanova Schistad 
Department of Physical Medicine and Rehabilitation, Oslo University Hospital, Ullevaal, P.O. 
Box 4956 Nydalen, 0424 OSLO, Norway. 
Tel: + 47 22 11 90 39; Fax: + 47 23 02 74 55 
E-mail: uxioel@ous-hf.no 
 
 
 
IL-6 and recovery in lumbar radicular pain  
 
2 
 
Abstract 
Background: In the present study the influence of cytokines on one-year recovery in lumbar 
radicular pain was examined. 
 
Methods: In total 110 patients with symptomatic lumbar disc herniation were followed for 
one year. Uni- and multivariate linear regression was used to assess the influence of IL-6, IL-
8, disc degeneration, and endplate changes (Modic changes) on the changes in the primary 
outcome Oswestry disability index (ODI change) and secondary outcomes VAS for low back 
pain (LBP) and leg pain.  
 
Results: Less favourable ODI outcome correlated with higher serum IL-6 levels (B =-3.41, 95% 
CI -5.52 to -1.30, p = 0.002), non-surgical treatment (B = -7.03, 95% CI 1.21 to 12.84, p = 
0.018), higher baseline back pain intensity (B =-2.28, 95% CI -3.21 to -1.35, p < 0.001), and 
low educational level (B = -5.57, 95% CI 0.66 to 10.47, p = 0.027). High VAS for LBP and 
leg pain at one year was associated with high levels of serum IL-6, higher back pain intensity 
and longer duration of lumbar radicular pain at baseline. 
 
Conclusions: High serum IL-6 levels, but not disc degeneration or Modic changes, were 
associated with less favourable recovery in patients with lumbar radicular pain. Intense initial 
back pain, non-surgical treatment, lower educational level, and longer duration of radicular 
pain before treatment also correlated with a slower recovery the first year after disc 
herniation.  
 
Keywords: lumbar radicular pain; low back pain (LBP); ODI (Oswestry disability index); 
cytokines (IL-6 and IL-8); endplate changes/Modic changes; disc degeneration; magnetic 
resonance imaging (MRI). 
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Introduction 
The recovery from lumbar radicular pain is influenced by psychosocial, surgery-related, 
clinical and biological factors. Particular, the role of biological factors predicting the recovery 
after symptomatic disc herniation is not fully understood. 
 
Psychosocial and emotional prognostic factors have been less well studied in radicular pain 
compared with LBP, but they do have an impact on recovery (Ashworth et al 11; den Boer et 
al 06; Haugen et al 12). Comorbid subjective health complaints, emotional distress, 
kinesiophobia, more LBP, longer duration of symptoms, smoking, clinical factors such as 
muscular weakness, and no surgical treatment are associated with non-success in lumbar 
radicular pain due to DH (Edwards et al 07; Haugen et al 12). Lower education level, which is 
often associated with environmental and occupational factors such as heavy physical work 
and low-decision authority, is known prognostic factors for poor recovery (Chibnall and Tait 
09; Keller et al 12). 
 
Regarding MRI findings, the morphometric features of the herniated disc and spinal canal 
may be useful when predicting the outcome from surgery (Carragee and Kim 97; 
Sutheerayongprasert et al 12). The type of treatment (surgical or conservative) may influence 
the short-term time course of patients with lumbar radicular pain. In contrast disc 
degeneration may not be associated with disability or pain at a one-year follow-up of patients 
with radicular pain (Jensen et al 10). A better understanding of the benefits and limitations of 
MRI in evaluating patients with symptomatic disc herniation may therefore be important for 
future treatment (Yong and Sutherland 12). 
 
Several lines of evidence (Burke et al 02; Kang et al 96; Kraychete et al 10) suggest that 
inflammation contributes to the pathogenesis of lumbar radicular pain due to disc herniation. 
Therefore, pro-inflammatory cytokines, specifically interleukins (ILs) and TNF-α, are 
potential biomarkers of disc degeneration and disc herniation. For example, previous data 
show that disc herniation increases the synthesis of matrix metalloproteinases, nitric oxide, 
prostaglandin E2, interleukin-6 (IL-6) (Kang et al 96) and IL-8 (Burke et al 02).The 
inflammatory response, initiated from the annulus fibrosus in case of disc herniation, may 
lead to increased levels of pro-inflammatory cytokines close to nerve roots. The inflammatory 
reaction around the herniated disc material also affects the nerve roots with disturbance of 
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intraradicular blood flow and breakdown of the blood-nerve barrier, resulting in intraradicular 
inflammatory changes such as edema and demyelination. Moreover, there is evidence that 
serum levels of IL-6 may be elevated in patients suffering from persistent radicular pain 8 
weeks after discectomy compared with healthy pain-free controls (Geiss et al 97). One cross-
sectional study also demonstrated elevated serum IL-6 levels in patients with chronic LBP due 
to herniated discs (Kraychete et al 10). However, the impact of IL-6 on the recovery rate of 
patients with lumbar radicular pain has not been evaluated in a prospective study. The aim of 
this prospective study was to examine the influence of such cytokines (IL-6 and IL-8) on one-
year recovery of patients with lumbar radicular pain. 
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Materials and Methods 
Study population 
Participants with lumbar radicular pain were recruited from those attending Oslo University 
Hospital in Ulleval between 2007 and 2009. The inclusion criteria were: age between 18 and 
60 years and lumbar disc herniation on MRI with corresponding distribution of pain in lower 
limbs and positive straight leg raising (SLR) test results. The exclusion criteria were as 
follows: lumbar spinal stenosis; previous spinal surgery for a herniated disc at the same level 
or lumbar fusion at any level; generalised musculoskeletal pain; inflammatory rheumatic 
disease; diabetic polyneuropathy; cardiovascular disease (New York Heart Association class 
III and IV); cancer; psychiatric disease; drug misuse and alcoholism; recent surgery (within 1 
month); pregnancy; poor proficiency in the Norwegian language and non-European-
Caucasian ethnicity. Patients with cauda equina syndrome were also excluded. In total, 121 
(81.8%) of the 148 patients who met the eligibility requirements were included in the intended 
follow-up assessment (Fig. 1). The drop-out rate was 9.1%, and ultimately, 110 patients were 
assessed at a one-year follow-up. The study was conducted in accordance with the Helsinki 
Declaration. The Regional Committee for Medical Research Ethics and the Norwegian Social 
Science Data Service approved the study protocol, and all participants gave their written 
informed consent to participate. 
 
Clinical procedures and outcome measures 
At the initial screening visit and at the one-year follow-up, patients underwent a standardised 
clinical examination, which included an assessment of sensory and motor function and 
completion of standardised pain, emotional distress and function questionnaires. Demographic 
data and an MRI scan were obtained upon inclusion in the study. Patients were not 
randomised to surgery, but selected by usual clinical assessment based on the presence of 
neurological deficits, intense radicular pain and disability. Surgical treatment was offered to 
patients with persistent radicular pain lasting more than 8 weeks, neurological deficits 
(sensory changes, muscle weakness or depressed or absent deep tendon reflexes) and 
corresponding MRI findings in the anticipated location. Patients who did not fulfil these 
criteria were managed conservatively, a pathway that comprised a brief cognitive intervention, 
activity guidance during the acute phase of disc herniation and, for the majority of patients 
(60.3%), physiotherapy. 
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In general both surgical and non-surgical patients received pharmacological treatment as 
either monotherapy or combined therapy according to usual clinical practice. In addition, 
most of the patients used paracetamol and non-steroidal anti-inflammatory drugs (NSAIDs). 
Opioid analgesics, antiepileptic and antipsychotic drugs were also prescribed if necessary. 
Regarding use of steroids, one surgical and one non-surgical patient received systemic 
corticosteroids in the acute phase of disc herniation and radicular pain. Finally, two 
conservatively managed patients received transforaminal epidural steroids injections.  
 
Socio-demographic variables and work-related factors such as marital status, duration of 
education, occupation, duration of sick leave and social benefits were also registered upon 
inclusion in the study. Occupations were classified into three groups: Mental, Mixed and 
Physical work (Ilmarinen et al 91). The demand and control subscales of the General Nordic 
Questionnaire for Psychological and Social Factors at Work (QPS Nordic) (Wannstrom et al 
09) were applied to record quantitative job demands and the control of work pacing. 
 
Pain intensity was recorded using the visual analogue scale (VAS) with anchor values from 0 
to 10 for present pain, pain during activity and pain at rest, with separate scales for LBP and 
leg pain. Patients were asked to report the mean pain intensity during the last week. The 
Hopkins Symptom Checklist (HSCL), a 25-item questionnaire, was used to register 
psychological distress (Derogatis et al 74); scores equal to or greater than 1.75 on the total 
scale indicated emotional distress (Sandanger et al 99). We used the validated Norwegian 
version of the Oswestry disability index (ODI, scale 0-100%, where 0% = no disability at all, 
and 100% = very severe disability) (Grotle et al 03). The Oswestry index was considered to 
be the most relevant score for the study of function and long-term outcome. Hence, the 
primary outcome measure in this study was ODI change, defined as the baseline ODI minus 
the ODI at the one-year follow-up. A higher value for ODI change indicates a more 
favourable functional outcome. 
 
Image evaluation 
Baseline lumbar 1.5 T or 1.0 T MRI examinations were performed as part of the clinical 
patient evaluation and included sagittal T2- and T1-weighted images and axial images. For 
the present study, all MRIs were de-identified and presented in random order. An experienced 
radiologist (AE) and a physical medicine and rehabilitation physician (EIS) were blinded to 
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the clinical data before independently grading the MRI scans for Modic changes (Modic et al 
88) and disc degeneration. At each of the 10 endplates from L1 to S1, AE and ES noted 
Modic changes as primary type I (hypointense T1- and hyperintense T2-signal), type II 
(hyperintense T1- and iso/hyperintense T2-signal) or type III (hypointense T1- and T2-
signal). Modic changes were classified into three groups as follows: no Modic changes, 
Modic type I, and Modic type II and III without type I. 
 
Disc degeneration was graded on mid-sagittal T2-weighted images at each of the five disc 
levels from L1 to S1 using Schneiderman’s grading system (Schneiderman et al 87): a score 
of 0 indicated no signal change, a score of 1 indicated a slight decrease in the signal intensity 
in the nucleus pulposus, a score of 2 indicated a generalised hypointense nucleus, and a score 
of 3 indicated a hypointense nucleus with disc space narrowing. The total disc degeneration 
score (0 – 15) across all five discs was calculated and then grouped according to Jim (Jim et al 
05) into severe (two or more grade 3 discs, three or more grade 2 discs, or one grade 3 and 
two grade 2 discs), moderate (one grade 3 disc or two grade 2 discs), mild (only one grade 2 
disc and no grade 3 discs), or normal (total disc degeneration score of 0 or 1). Disc 
degeneration was analysed as the total score and as a grouped variable. In all cases of 
disagreement, a consensus score was negotiated. In a sample of 275 patients with 
symptomatic disc herniation including the study cohort, the two observers achieved relatively 
consistent inter-observer agreement on the type of the Modic changes (kappa 0.59-0.77) at 
endplates with at least 10% prevalence of Modic changes (L2-S1), ensuring interpretable 
kappa values (Sim and Wright 05). In instances of at least 10% prevalence of disc 
degeneration with a score of 2 or 3 (also L2-S1), inter-observer agreement on disc 
degeneration was moderate or good (linearly weighted kappa 0.54-0.67). 
 
ELISA measurements of cytokine concentration in serum 
Blood samples were drawn during the initial screening visit at the hospital. A few patients, 
who had to wait for surgery longer than 8 weeks, were re-included with new blood samples. 
The serum analysis of the blood samples was performed at the National Institute of 
Occupational Health, Oslo. Laboratory method: After being on ice for 45 minutes, blood 
samples were centrifuged for 10 minutes at 40C and 2000 G. Further, serum was stored in 
duplicate at -800C until use. The serum concentrations of the two pro-inflammatory cytokines 
IL-6 and IL-8 were determined by the use of commercial enzyme-linked immunosorbent 
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assay kits according to the manufacturer’s instructions (human ultrasensitive kits for IL-6 and 
IL-8, Invitrogen Corporation, CA, USA). Briefly, 100 μl of serum or IL-6 or IL-8 standard 
was added to each well in microtitre plates pre-coated with an antibody specific for each 
cytokine, and the plates were incubated at room temperature. After washing the plates, 100 μl 
of biotinylated antibody specific for IL-6 or IL-8 was added, and the plates were incubated at 
room temperature. After removal of excess secondary antibody by washing, 100 μl of 
streptavidin-conjugated horseradish peroxidase enzyme solution was added to each well. 
After incubating the plates at room temperature and washing the plates to remove all unbound 
enzyme, a substrate solution with chromogen was added to produce colour. The reaction was 
stopped by adding 100 μl of stop solution. The optical density was measured at a wavelength 
of 450 nm using a Fusion Universal Microplate analyser (Packard Instrument Company, 
Meriden, CT, USA). Data were analysed using the Fusion data analysis software program 
(Packard Instrument Company). The amount of IL-6 and IL-8 in all samples was quantified 
based on a standard curve prepared for each analysed cytokine. Background absorbance was 
subtracted from all data points including the unknown samples and the standards. Serum 
collected at three different time points for each patient was analysed on the same microtitre 
plate. Serum IL-6 was measured in pg/ml. According to the manufacturer, the minimum 
detectable dose of IL-6 and IL-8 was 0.15 pg/ml and 0.4 pg/ml, respectively. 
 
Statistical analyses 
Pain and function scores between the surgery and non-surgery groups were compared using t-
tests at baseline and one-year follow-up. Daily use of pain medication and neurological 
deficits between the surgery and non-surgery groups were compared using Chi-square tests at 
baseline and one-year follow-up. After Bonferroni adjustment for comparison at two different 
time points, p ≤ 0.025 (p ≤ 0.05/2) was regarded as statistically significant in these 
comparative analyses.  
 
The relationship between potential prognostic variables and the ODI change was determined 
using linear regression analysis. Analysed variables included serum cytokine concentrations, 
pain intensity, emotional distress and functioning, neurological deficits, daily use of 
analgesics and co-analgesics, Modic changes, disc degeneration and the following 
demographic data: age; sex; marital status; educational level; employment (full-time job or 
not); profession and QPS Nordic job demands and control of work pacing (Table 1). 
IL-6 and recovery in lumbar radicular pain  
 
9 
 
Interleukin-6 was analysed as continuous variable. HSCL-25 data were dichotomised using 
the cut-off point 1.75 (Sandanger et al 99) for the purpose of the regression analysis. 
 
In the next step, variables with a p-value <0.1 based on the univariate regression analysis 
were included in a stepwise multivariate regression analysis with the ODI change as the 
dependent variable. Each analysis was adjusted for the baseline value of the ODI. In a forward 
stepwise procedure, the independent variables with the largest p-value were excluded until all 
of the remaining variables showed a p-value below 0.05. Statistical assumptions were met as 
influence and leverage statistics were within a normal range. The variance inflation factors 
(VIFs) of the multiple regression analysis were within the acceptable range (VIF <10), 
suggesting acceptable co-linearity. Residual statistics revealed high Mahalanobis distance 
values in two patients. These patients were excluded from the analysis because these 
participants would otherwise have had too large an influence on the regression coefficient 
(Jeng and Martin 85). The residuals in the regression model showed a normal distribution. 
Missing pain scores (2%) were replaced with the mean value for each treatment group. 
Regarding other independent values there were no missing values. Multivariate regression 
analysis was supplied with the additional endpoint parameters VAS for LBP and VAS for leg 
pain separately. Each analysis with additional endpoints was adjusted for the baseline value of 
the VAS for LBP and leg pain, respectively. Statistical analyses were performed using the 
statistical package PASW statistics 19 (SPSS Inc., Chicago, IL, USA). 
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Results 
Baseline characteristics of the 108 analysed patients with lumbar radicular pain are shown in 
Table 1. Seventy-five patients (69%) had neurological deficits, three of whom had paresis 
(drop-foot) during heel-toe walking. Forty patients (37%) were treated surgically, most by 
microdiscectomy. The mean time from baseline to surgery was 6.7 weeks (SD 6.0). Sixty-
eight (63%) patients were managed conservatively. At baseline, patients treated with surgery 
showed poorer function than patients treated without surgery (mean ODI change of 28.0, SD 
18.1 versus mean ODI change of 9.4, SD 15.3), and they showed a higher mean VAS for leg 
pain (Table 2a). Daily use of analgesics or co-analgesics and neurological deficits in patients 
treated with and without surgery are shown in Table 2b. At baseline, we did not observe any 
difference in the use of paracetamol, antiepileptic or antipsychotic drugs between surgical and 
non-surgical patients. Nevertheless, surgical patients used NSAIDs and opioids more 
frequently than the non-surgical patients (Table 2b). As expected, at the one-year follow-up, 
the daily use of all analgesics and co-analgesics had been reduced in both groups. At one-year 
follow-up, 33% in the surgery group and 15% in the non-surgery group used analgesics. 
However, no clear statistical difference between the groups was observed; the Chi-square test 
for independence (with Yates’ continuity correction) indicated no significant association 
between use of analgesics at one-year follow-up and treatment, χ2 (1, n = 108) = 0.21, p = 
0.053, phi = 0.21. Regarding the baseline serum IL-6 levels (mean = 1.02; SD = 1.14; range 0 
– 6.32), there was no significant difference in IL-6 levels between the surgery and non-
surgery groups (surgery mean = 0.9, SD = 0.9, non-surgery mean = 1.1, SD = 1.3; Student’s t-
test t (102) = 0.8, p = 0.44).  
 
Function improved during the one-year follow-up (mean ODI change of 16.5, SD 18.7). 
Results from the linear regression analysis of potential predictors of ODI change during the 
one-year follow-up after adjusting only for baseline ODI are shown in Table 3. The following 
variables had significant prognostic value (with a p-value < 0.1) for ODI change: serum IL-6 
concentration, surgery, VAS for back pain, VAS for current back and leg pain, duration of 
lumbar radicular pain, educational level, HSCL-25, and smoking (Table 3). Modic changes, 
disc degeneration and daily use of pain medications were not significant prognostic factors. 
The results of the stepwise multivariate regression are shown in Table 4. The baseline value 
for ODI was included as an independent variable in the analysis. High levels of serum IL-6, 
non-surgical treatment, high LBP intensity, and lower educational level inversely correlated 
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with recovery and accounted for 58% of the variance in the ODI change together with the 
baseline functional level. The results of stepwise multivariate regression with the additional 
endpoint parameters VAS for LBP and for leg pain separately at one-year follow-up are 
shown in Tables 5 and Table 6, respectively. High levels of serum IL-6, high LBP intensity, 
and longer duration of lumbar radicular pain at baseline correlated with high VAS for LBP 
and accounted for 34% of the variance in the VAS for LBP at one-year follow-up. High levels 
of serum IL-6, high intensity of LBP, and longer duration of lumbar radicular pain at baseline 
correlated with high VAS for leg pain and accounted for 25% of the variance in the VAS for 
leg pain at one-year follow-up. 
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Discussion 
This study is the first to show an association between serum IL-6 levels and recovery of 
patients with lumbar radicular pain after disc herniation when adjusted for other relevant risk 
factors. In addition to high initial back pain intensity, non-surgical treatment, lower 
educational level and longer history of lumbar radicular pain prior to treatment, high IL-6 
levels had a negative impact on the long-term recovery rate of patients with symptomatic disc 
herniation. However, Modic changes and disc degeneration had no impact on recovery at one-
year follow-up. 
 
Patients with intense initial back pain showed less improvement in pain and function at one-
year follow-up, a finding that is consistent with previous observations (Jensen et al 10). 
Moreover, patients with high levels of serum IL-6 also showed less improvement. This 
demonstrates that intense pain and high levels of inflammatory cytokines such as IL-6 are risk 
factors for long-term disability in patients with lumbar radicular pain. A previous study 
(Binshtok et al 08) has shown that in addition to producing inflammation and inducing the 
synthesis of several nociceptor sensitisers, the pro-inflammatory cytokine IL-1 rapidly and 
directly activates nociceptors to generate action potentials and induce pain hypersensitivity. 
An increased release of IL-1β will also probably increase the levels of other cytokines 
including IL-6 and vice versa (Kang et al 97). Hence, our findings support the concept that 
pro-inflammatory cytokines may promote pain.  
 
Previous studies (Verri, Jr. et al 06) have shown that IL-1 and tumour necrosis factor (TNF) 
contribute to the activation of inflammatory immune cells, which may lead to the sensitisation 
of peripheral nociceptive nerve fibres. Moreover, IL-1β induces central cyclooxygenase-2 
(Cox-2) upregulation, which results in an increase in the synthesis of prostaglandin E2 (PGE2) 
in spinal cord neurons or other regions of the CNS. Induction of Cox-2 expression and the 
production of prostanoids induce central hypersensitivity. Our study shows an association 
between serum IL-6 concentration at baseline and long-term disability in lumbar radicular 
pain. However, the population was too small to study the effects of IL-6 separately in patients 
who received surgery compared with those managed conservatively.  
 
Regarding the effect of treatment, we observed that patients managed conservatively had less 
favourable recoveries at the one-year follow-up. These results are consistent with recent 
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studies (Haugen et al 12; Jacobs et al 11) indicating that surgery provides more rapid relief of 
pain and disability without improving the long-term course of lumbar radicular pain (Atlas et 
al 05). The benefits of surgical treatment become less pronounced with time. Surgery is 
usually considered in a minority of patients with disc herniation. In the initial course of 
radicular pain due to disc herniation, physicians commonly recommend conservative 
treatment for at least 2 months before surgical intervention unless severe neurological 
deterioration occurs (Orief et al 12). Notably, the group of patients in our study who received 
surgery was initially different from the conservatively managed group, as the former reported 
more intense leg pain and greater disability. Further, patients who underwent disc herniation 
surgery had higher consumption of pain medication at baseline, compared to the non-surgery 
group. Hence, these two groups of patients demonstrated differences at the baseline of the 
study, and thus cannot be directly compared regarding the treatment. However, differences in 
the use of pain medications at baseline had no impact on improvement of function at one-year 
follow-up.  
 
Earlier data show that lower educational level was associated with poor recovery (Keller et al 
12). Lower education is often associated with low-decision authority and heavy physical work, 
which are well-known prognostic factors for poor recovery (Chibnall and Tait 09;Keller et al 
12). Education is also a part of the biopsychosocial model, which is important for the 
understanding of different contributory causes to the development of chronic pain and 
disability. Earlier studies have shown that emotional distress is a risk factor for reduced 
treatment benefit (i.e., less improvement over a 3-year follow-up) in patients with radicular 
pain (Edwards et al 07). Thus comorbidities should be assessed in patients with radicular pain 
as well (Haugen et al 12). However, since comorbid disease was adapted as an exclusion 
criterion, 57.4% of patients had a low HSCL-25 score; and HSCL had no significant influence 
on recovery from radicular pain. 
 
As one might expect we found that patients with a longer history of lumbar radicular pain had 
higher VAS for LBP and leg pain at the one-year follow-up. Thus, our study suggests that 
patients who have suffered pain for a longer period before receiving treatment may have had a 
more severe pain condition, which translates to less favourable recovery relative to other 
patients. It is therefore likely that the longer duration of radicular pain may increase the 
activity in the pain pathways to the brain, which lead to central sensitisation. In fact, several 
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lines of evidence indicate that such central sensitisation may contribute to the development of 
persistent pain.  
 
Conclusions 
The present data demonstrated that high levels of serum IL-6, but not disc degeneration or 
Modic changes, were associated with less favourable recovery in patients with lumbar 
radicular pain. Intense initial back pain, conservative management, lower educational level, 
and an extended duration of radicular pain before treatment also correlated with a slower 
recovery at one-year. 
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Figure legends: 
Figure 1: Flow diagram of study population. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1
Assessed eligible (n=148) 
Allocated to follow-up (n=121)
Declined to participate (n=17)
Excluded (n=4)
Missing of VAS, ODI, McGill  (n=4), MRI 
(n=1) and blood samples (n=1) at baseline
Drop-out (n=11)
Follow-up at 12 months  (n=110)
Final sample  (n=108)
High Mahalanobis distance value (n=2)
 
Table 1. Characteristics of study population at baseline. Data presented as mean (SD) or 
number of patients (%). 
Characteristics All patients (n=108) 
 
 
Demographics: 
Age (years) 41.3 (10.0) 
Males 48 (44%) 
Smokers 38 (35%) 
Marital status: married, cohabitant, 
partner/else 
59 (55%)/49 (45%) 
Higher education 53 (51%) 
Full-time job 84 (82%) 
                  of whom on sick leave 56 (52%) 
Profession (mental/mixed/physical) 67 (62%)/21 (19%)/15 (14%) 
QPS Nordic quantitative job demands 2.9 (1.1) 
QPS Nordic control of pace of work 3.0 (1.3) 
 
Neurological deficits: 
Sensory deficit 60 (56%) 
Motor deficit 32 (30%) 
Reflex loss or deficit 31 (29%) 
 
Cytokines: 
IL-6 protein in serum (pg/ml) 1.02 (1.14) 
IL-8 protein in serum (pg/ml) 3.38 (3.72) 
 
Pain, emotional distress and functioning: 
ODI 35.5 (17.3) 
VAS for LBP 3.7 (2.7) 
VAS for leg pain 5.9 (2.8) 
VAS for pain during activity 5.7 (2.7) 
VAS for pain at rest 3.8 (2.6) 
Duration of sciatica (weeks) 20.3 (19.9) 
HSCL-25 ( ≥ 1.75) 46 (43%) 
 
Pain medications: 
Daily used any type of pain medication  53 (49%) 
 
Modic changes and disc degeneration: 
Presence of Modic type I 16 (15%) 
Presence of Modic type II or III (but not I) 67 (62%) 
Disc degeneration total score 5.9 (1.9) 
Disc degeneration grouped according to 
Jim: 
 
mild 15 (14%) 
moderate 54 (51%) 
severe 38 (36%) 
 
 Table 2a. Pain intensity and functional level at baseline in patients with lumbar 
radicular pain, treated with and without surgery. Data presented as mean (SD). 
 
 
 
 
 
 
 
Table 2b. Use of analgesics or co-analgesics and the presence of neurological deficits at 
baseline in patients with lumbar radicular pain, treated with and without surgery. Data 
presented as mean (SD). 
 
 
*with Yates Continuity Correction 
 
 Surgery (n=40) Non-surgery (n=68) T-test 
p-value 
 
VAS leg pain  7.3 (2.4) 5.0 (2.7) p < 0.001 
VAS back pain  4.1 (2.8) 3.5 (2.6) p = 0.27 
ODI  
 
47.1 (17.4) 28.7 (13.3) p < 0.001 
 Surgery 
(n=40) 
Non-surgery 
(n=68) 
Pearson Chi 
square* p-value 
Daily use of analgesics 
or co-analgesics, of 
whom  
NSAIDs  
opioids 
29 (73%) 
 
 
22 (55%) 
18 (45%) 
25 (37%) 
 
 
16 (24%) 
7 (10%) 
p = 0.001 
 
 
p = 0.002 
p < 0.001 
 
Sensory deficit 25 (63%) 35 (51%) p = 0.36 
 
Motor deficit 13 (33%) 18 (27%) p = 0.65 
 
Reflex loss or deficit 
 
14 (35%) 18 (27%) p = 0.47 
Table 3. Results of linear regression analyses with ODI change as dependent variable. 
Each independent variable was analysed separately. ODI at baseline was included as the 
independent variable in each analysis. Variables with a significance level p <0.1 are shown. 
 
 
Independent variables at baseline 
 
 β               B               95% CI for B              p-value 
 
IL-6 protein (pg/ml) 
 
 -0.22           -3.54          -5.96 to -1.12            p = 0.005   
 
Surgery (yes vs. no) 
 
 0.25            9.56             3.11 to 16.02            p = 0.004  
 
VAS for back pain  
(1 cm increase) 
 
 -0.34           -2.35           -3.35 to -1.34           p < 0.001   
 
VAS for current back and  
leg pain (1 cm increase) 
 
 -0.18           -1.28           -2.71 to 0.16             p = 0.080  
Duration of radicular pain  
(one week increase) 
 
 -0.23           -0.21           -0.35 to -0.08           p = 0.002   
 
Educational level  
(higher education vs. else) 
 
 0.17            6.26             0.74 to 11.78            p = 0.027  
 
HSCL-25 (above or equal vs. below 1.75) 
 
 -0.17           -6.53           -12.28 to -0.77         p = 0.027   
 
Smoking (yes vs. no) 
 
 -0.14           -5.26           -11.06 to 0.55           p = 0.075 
 
 
 
 
 
 
 
 
 
 
 
Table 4. Results of multivariate linear regression analyses with ODI change as the 
dependent variable. Variables with a significance level p <0.05 are shown. 
 
Independent variables at 
baseline 
                Adjusted results 
β              B              95% CI for B         p-value 
IL-6 protein (pg/ml) -0.18          -3.41         -5.52 to -1.30      p = 0.002   
 
Surgery (yes vs. no) 0.22           7.03           1.21 to 12.84      p = 0.018   
 
VAS for back pain (1 cm increase) -0.33          -2.28         -3.21 to -1.35      p < 0.001   
 
High education (no vs. yes) 0.15           5.57           0.66 to 10.47      p = 0.027   
 
ODI (per unit) 
 
0.67           0.75           0.58 to 0.93        p < 0.001   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5. Results of multivariate linear regression analyses with VAS for LBP at one-year 
follow-up as the dependent variable. Variables with a significance level p <0.05 are shown. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Independent variables at baseline                 Adjusted results 
β               B             95% CI for B              p-value 
IL-6 protein (pg/ml) 
 
0.24             0.64           0.21 to 1.07      p = 0.004 
VAS for back pain (1 cm increase) 0.46             0.52           0.34 to 0.71      p < 0.001 
 
Duration of radicular pain (weeks) 
 
0.24             0.04           0.01 to 0.61      p = 0.005 
Table 6. Results of multivariate linear regression analyses with VAS for leg pain at one-
year follow-up as the dependent variable. Variables with a significance level p <0.05 are 
shown. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Independent variables at baseline                          Adjusted results 
 β                B                95% CI  for B           p-value 
IL-6 protein (pg/ml) 
 
 0.29             0.81         0.32 to 1.29          p = 0.001 
VAS for LBP (1 cm increase) 
 
 0.31             0.35         0.15 to 0.55         p = 0.001 
 
Duration of radicular pain (weeks) 
 
 0.25             0.04         0.01 to 0.07         p = 0.006 
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Abstract 
Objective. To examine whether Modic changes influence pain during one-year follow-up in 
patients with lumbar radicular pain. 
 
Materials and Methods. A total of 243 patients with lumbar radicular pain due to disc 
herniation were recruited from two hospitals in Norway and followed up at 6 weeks, 6 
months, and 12 months. On baseline lumbar magnetic resonance images, two observers 
independently evaluated Modic changes (type I-III; craniocaudal size 0-3). Primary outcomes 
were sensory pain (McGill Pain Questionnaire) and back pain scores (visual analogue scale, 
VAS). Impact of Modic type and size on outcome at each time point was explored using two-
way analyses of variance with Modic and treatment groups (surgical, n = 126; nonsurgical, n 
= 117) as fixed factors and disc degeneration, age, sex, smoking, and duration of lumbar 
radicular pain as covariates. 
 
Results. Pain scores had decreased significantly at 12 months follow-up. Modic type showed 
a significant impact on McGill sensory score at 6 weeks (p = 0.007), but not at other time 
points or on VAS back pain or VAS leg pain scores. At 6 weeks, the mean McGill sensory 
score was higher in Modic I than in Modic II-III patients (p = 0.003) and in patients without 
Modic changes (p = 0.018). Dichotomized Modic size L1-S1 had no impact on McGill 
sensory, back pain, or leg pain scores. 
 
Conclusion. Patients with lumbar radicular pain have a substantial pain reduction during one 
year follow-up, but Modic type I changes may imply a slower initial decrease in sensory pain. 
 
 
 
Keywords: low back pain, lumbar radicular pain, magnetic resonance imaging, Modic 
changes, spine, disc degeneration. 
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Introduction 
Lumbar radicular pain constitutes only 5%-10% of low back pain (LBP) conditions [1], but it 
accounts for 33% of the sick leave and 47% of the disability benefits due to such conditions in 
Norway [2]. It has been suggested that Modic changes may be important for lumbar 
radicular pain [3]. However, the potential impact of Modic changes on recovery and pain is 
still debated [4-6].  
 
The essential symptom of lumbar radicular pain is radiating pain in an area of the leg typically 
innervated by one nerve root in the lumbar or sacral spine [1, 7]. Although the prognosis is 
good, a substantial proportion of affected patients (up to 30%) continue to have pain for 1 
year or longer [8]. Patients with radicular leg pain due to a disc herniation often have 
concurrent LBP, which hampers recovery [9]. Modic changes are common in disc herniation 
patients [3], and assumed to be related to the LBP in these patients [10]. Modic changes are 
defined as signal-intensity changes in the vertebral body marrow adjacent to the endplate that 
are verifiable on magnetic resonance imaging (MRI) [11]. Previous research has shown that 
the Modic classification is reliable, reproducible, and can be applied in clinical practice [12]. 
The prevalence of Modic changes increases with age, and is lower in nonclinical populations 
than among patients with chronic LBP, with prevalence rates of 6% and 81%, respectively 
[10, 13]. Moreover, in an earlier study of disc herniation patients with acute and chronic 
lumbar radicular pain, the prevalence of Modic changes was 25% and increased to 49% at 14 
months follow-up [3]. Much of the increase was due to development of type I Modic changes, 
which are associated with edema and inflammation [3, 14]. However, in previous studies [15, 
16], Modic type I did not affect long-term recovery from back pain after surgery with 
discectomy. Earlier data show that surgery may provide an initial pain relief, but does not 
improve the long-term outcome after symptomatic disc herniation [17, 18]. The aim of the 
present study was to examine whether Modic changes influence pain during one-year follow-
up in patients with lumbar radicular pain. 
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Materials and Methods 
This prospective study was approved by the Regional Committee for Medical Research Ethics 
in Norway. All participants gave their written informed consent. 
 
Eligibility criteria and study population 
Participants with lumbar radicular pain were recruited from Oslo University Hospital, Ulleval 
and Haukeland University Hospital between September 2007 and October 2009. 
 
The inclusion criteria were an age of 18 to 60 years, lumbar disc herniation on MRI with 
corresponding radicular pain, and a positive straight leg raising test result. A positive straight 
leg raising test was defined by radiating pain into one or both legs when the examiner raises 
the straightened limb slowly until 60 degrees. The test was performed in supine position and 
supplemented with slight dorsiflexion of the foot. 
 
The exclusion criteria were symptomatic lumbar spinal stenosis, spinal surgery for a herniated 
disc at the same level or fusion at any level in the lumbar spine, generalized musculoskeletal 
pain, inflammatory rheumatic disease, diabetic polyneuropathy, cardiovascular disease (New 
York Heart Association functional classes III and IV), cancer, psychiatric disease, drug abuse 
or alcoholism, recent completion of another surgery (within 1 month), pregnancy, poor 
proficiency in the Norwegian language, and non-European Caucasian ethnicity. 
 
A total of 262 (87.6%) of the 299 patients assessed for eligibility were included. However, 
because 19 patients had missing baseline data, 243 (81%) of the 299 patients were allocated to 
follow-up and included in the present analyses. Fig. 1 shows an overview of participant flow 
through the trial. Only 18 (7%) of the 243 patients dropped out of the study. 
 
Clinical procedures and outcome measures 
At baseline, all 243 patients underwent a standardized clinical examination including 
assessment of sensory and motor function. The validated Norwegian version of the McGill 
Pain Questionnaire (MPQ) [19] was used to measure sensory, affective and evaluative aspects 
of the pain experience. The sensory component of the MPQ was chosen as an essential 
variable for pain perception [20]. We chose to use the Norwegian version of MPQ [19] that 
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contained 76 descriptors of sensory pain in 12 groups, i.e. 76 pain adjectives (e.g., tingling, 
dull, biting, sharp). Each adjective’s pre-defined attached VAS score was used to calculate a 
mean score for the selected adjective(s) within each of the 12 groups [19]. The McGill 
sensory score (a ratio between 0 and 1) was the sum of these mean scores for all 12 groups 
(reflecting the strength of all selected adjectives in the sensory component of the MPQ) 
divided by the highest possible sum score. In addition, average pain intensity during the last 
week was examined separately for LBP and for leg pain using a VAS with anchor values from 
0 (no pain) to 10 (worst imaginable pain) [21]. For registration of function disability the 
validated Norwegian version of the Oswestry Disability Index (ODI) (scale, 0–100%; 0% = 
no experienced disability, 100% = very severe disability) was used [22]. Sociodemographic- 
and work-related factors such as years of education, profession, duration of sick leave, and 
social benefits were also registered. 
 
At the 6-week follow-up, the same measures sampled at inclusion, with the exception of MRI, 
were again evaluated. At the 6-month follow-up, patients were contacted by telephone 
regarding changes in their spinal condition and work status and were sent the VAS, McGill, 
and ODI questionnaires by mail. At the 12-month follow-up, all measurements were repeated, 
and lumbar MRI was repeated if pain was persistent. We selected the McGill sensory score 
and the VAS score for LBP (i.e. back pain) as the most relevant primary outcome measures 
for assessing the back pain experience. The VAS score for leg pain was used as a secondary 
outcome. 
 
Image evaluation 
Baseline lumbar MRI (1.5 T in 86% of the cases, 1.0 T in 12%, 3.0 T or unknown in 2%) was 
performed as part of clinical practice using recommended sequences [23]. The images applied 
in this study were: 1) sagittal T2 weighted fast spin echo (n = 231; repetition time (TR)/echo 
time (TE), 2,900-4,500 ms/85-130 ms) and 3-D turbo spin echo (SPACE) images (n = 12; 
TR/TE, 1,500 ms/251 ms) and 2) sagittal T1 weighted spin echo (n = 226; TR/TE, 350-750 
ms/9-15 ms) and fast fluid-attenuated inversion-recovery images (n = 17; TR/TE, 1,989 ms/20 
ms). Axial images of the L3/L4, L4/L5 and L5/S1 levels were also available. Restore, Fast 
Recovery, or DRIVE T2 weighted images were not used, since a short TR might have 
affected the signal intensity. For this study, all MRIs were de-identified and presented in 
random order. 
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A radiologist with 28 years of experience and a physical medicine and rehabilitation physician 
with 6 years of experience, independently and blinded to clinical data, graded Modic changes 
[11] and disc degeneration (DD). DD is related to Modic changes [13] and was used as a 
covariate in the analyses. At each of the 10 endplates of L1–S1, Modic changes were noted as 
primary type I (hypointense T1 signal and hyperintense T2 signal), type II (hyperintense T1 
signal and iso- or hyperintense T2 signal), or type III (hypointense T1- and T2 signal) (Fig. 2). 
The craniocaudal (CC) size of the Modic changes was graded as <10%, 10%–25%, ≥25%– 
50%, or >50% of the vertebral body height [24]. In the final analyses, the first two CC size 
categories received a score of 0, and the subsequent categories received scores of 1, 2, and 3, 
respectively. A total CC size score for the 10 endplates was calculated (possible values 0-30). 
 
DD was graded on midsagittal T2 weighted images at each of the five disc levels (L1–S1) 
using Schneiderman’s grading system [25]: a score of 0 indicated no signal change, a score of 
1 indicated a slight decrease in signal intensity in the nucleus pulposus, a score of 2 indicated 
a generalized hypointense nucleus, and a score of 3 indicated a hypointense nucleus with disc 
space narrowing. The total DD score (0–15) across all five discs was calculated and then 
grouped according to Jim [26] into severe (two or more grade 3 discs, three or more grade 2 
discs, or one grade 3 and two grade 2 discs), moderate (one grade 3 disc or two grade 2 discs), 
mild (only one grade 2 disc and no grade 3 discs), or normal (total DD score of 0 or 1). 
 
The radiologist assessed all MRIs on a clinical Picture Archiving and Communication System 
(PACS) unit using the Agfa Impax 4.5 (Agfa HealthCare, Mortsel, Belgia) software. The 
other observer used a dedicated personal computer at the clinic. In all cases of disagreement, a 
consensus score was negotiated using the PACS unit. The independent evaluations showed 
mostly good interobserver agreement on type and CC size of Modic changes (kappa 0.58- 
0.77) at endplates with at least 10% prevalence of Modic changes and thus interpretable kappa 
values [27] (Table 1). Interobserver agreement on DD was moderate or good (kappa 0.54- 
0.67) at disc levels with at least 10% prevalence of a DD score of 2 and 3 (Table 1). 
 
Statistical analyses 
Each patient was classified as having 1) no Modic changes, 2) Modic type I changes, or 3) 
Modic type II and/or III, but not type I changes. The total Modic CC size score was close to 
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being normally distributed and was dichotomized at its mean. Paired t-tests were used to 
assess differences in pain scores between inclusion and 12 months. The impact of Modic type 
and size on each outcome (McGill sensory, VAS back pain, and VAS leg pain score) at 
baseline, 6 weeks, 6 months, and 12 months was evaluated by two-way analysis of variance at 
each time point, with the Modic and treatment groups (surgery vs. non-surgery) as fixed 
factors and the DD groups, age (continuous variable), sex, smoking status (current smoker, 
yes/no), and duration of lumbar radicular pain (< 3 months vs. ≥ 3months) as covariates. Pain 
scores between the Modic type groups were also compared using post hoc two-way analyses 
of variance adjusted for treatment (surgery vs. non-surgery). Missing pain scores were 
replaced with the mean value for each Modic group. After Bonferroni adjustment for 
comparison at four different time points, p ≤ 0.013 (p ≤ 0.05/4) was regarded as statistically 
significant. The analyses were conducted using SPSS version 19 (SPSS Inc., Chicago, IL). 
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Results 
Baseline characteristics of the 243 patients with lumbar radicular pain (Table 2) showed that 
111 patients (45.7%) had had pain for more than 3 months. A total of 184 (75.7%) patients 
had Modic changes at one or more endplates, and 163 (67.0%) patients had Modic changes 
with a CC size of at least 10% of the vertebral height. Moreover, 30 (12.4%) patients had 
Modic I changes, 147 (60.4%) had Modic II (but not Modic I) changes, and 7 (2.9%) had 
Modic III (but not Modic I or II) changes. Modic changes were most frequent at the L5–S1 
level (57.0% of cases) and the L4–L5 level (48.3% of cases) with decreasing frequency in the 
upper lumbar levels. The mean total Modic CC size score was 3.2 (standard deviation = SD, 
3.7; range, 0–24). All 243 patients had DD, which was mild in 45 (18.5%) patients, moderate 
in 115 (47.3%), and severe in 83 (34.2%). 
 
Treatment groups 
Surgery for disc herniation was performed in 126 (51.9%) patients. The type of surgery was 
known for 91 patients: 69.2% had microdiscectomy, 19.8% decompression, and 11% standard 
discectomy. A total of 117 (48.1%) patients underwent non-surgical treatment including 
adapted activity in the acute phase of disc herniation and physical therapy in cases of 
spontaneous regression of radicular pain. 
 
Pain symptoms at 12 months follow-up 
From inclusion to 12 months follow-up, a decrease (p < 0.001) was observed in mean McGill 
sensory score (from 0.53; SD, 0.23 to 0.27; SD, 0.27) (Table 3), mean VAS back pain score 
(from 3.97; SD, 2.68 to 2.46; SD, 2.76) (Table 3), and mean VAS leg pain score (from 6.26; 
SD, 2.81 to 2.01; SD, 2.65). Still, at 12 months, 71 (31%) of the 225 patients participating in 
this follow-up had back pain and 56 (25%) had leg pain, defined as VAS scores above 3.  
 
Influence of Modic changes on pain symptoms 
Modic type had a significant influence on the McGill sensory pain score at 6 weeks (F (2, 
223) = 5.06, p = 0.007), but not at inclusion, at 6 months, or at 12 months (Fig. 3). The 
McGill sensory score at 6 weeks was higher in the Modic type I group (mean, 0.45; SD, 0.28) 
than in the Modic type II and III group (mean, 0.29; SD, 0.23) (p = 0.003) and in the no- 
Modic group (mean, 0.30; SD, 0.24) (p = 0.018). There was no significant interaction between 
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Modic types and treatment. Neither the VAS back pain score (Fig. 4, Table 3) nor the VAS 
leg pain score differed significantly between Modic type groups at any time point. There was 
no significant effect of total Modic CC size on McGill sensory, back pain, or leg pain scores. 
Regarding the covariates, treatment (surgery vs. non-surgery) affected VAS leg pain at all 
time points (p ranged from < 0.001 to 0.013) adjusted for Modic type/size. Smoking in 
contrast only influenced VAS back pain at inclusion (p = 0.006 and 0.010) and McGill 
sensory pain at 6 months (p = 0.008 and 0.004) adjusted for Modic type/size. In addition, the 
duration of lumbar radicular pain affected VAS back pain at 12 months (p = 0.003 and 0.003) 
adjusted for Modic type/size. 
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Discussion 
A substantial pain reduction was observed during the 12-month follow-up in these patients 
with lumbar radicular pain with and without Modic changes. However, patients with Modic 
type I changes had higher sensory pain scores than other patients at 6 weeks. Moreover, at 12 
months, 31% of the patients in our study reported LBP and 25% reported leg pain. Although 
most patients with lumbar radicular pain due to disc herniation have spontaneous regression 
of symptoms [28], such pain is associated with high consumption of health resources [2]. 
More than 70% of the present patients had Modic changes, and more than 60% had Modic 
changes with a CC size of at least 10% of the vertebral height, which is a higher prevalence 
than that found among patients with lumbar radicular pain due to disc herniation in a previous 
study (range, 25%–49%) [3]. This can be partly explained by the duration of pain before 
inclusion in our study population (up to 4 years, Table 2). Recruitment from university 
hospitals may favor a high prevalence of Modic changes because the patients may have 
experienced pain for a longer time. Still, the prevalence of Modic changes increases during 
follow-up of patients with lumbar radicular pain [3]; it is also higher in patients with chronic 
versus acute LBP [13, 29]. Previous data [3] obtained from patients with lumbar radicular 
pain show that disc herniation is a strong risk factor for developing Modic changes (especially 
type I) during the following year. 
 
In our study, patients with Modic type I changes had a higher McGill sensory pain score at 6 
weeks compared to patients with other Modic types or without Modic changes. This result 
indicates a slower recovery after symptomatic disc herniation among patients with Modic type 
I changes, perhaps due to inflammatory back pain associated with Modic type I [30-32]. 
Previous studies have shown an increased frequency of Modic type I changes in individuals 
with LBP [3, 29]. Here, we have extended these findings and demonstrated that Modic type I 
changes also influence the recovery in lumbar radicular pain. The increased sensory pain in 
patients with Modic type I changes is clinically important. For example, patients with Modic 
type I may be informed that recovery may take more than 6 weeks, but that their prognosis is 
still good. In addition, it may be favorable with longer follow-up of these patients. 
 
Earlier studies showed that Modic type I changes do not predict back pain at 12 months after 
disc herniation surgery [16, 33]. Consistent with previous observations [34], our data showed 
no clear long-term association between Modic size and LBP. Importantly, our study was not 
Modic changes and recovery in lumbar radicular pain 
11 
 
designed to assess the effect of surgery; that would require a randomized controlled trial 
design. Surgery is an option in the minority of patients with neurological deficits or lack of 
improvement. Because of the often observed favorable natural recovery of lumbar radicular 
pain, non-surgical treatment for at least 6 weeks is common before surgery. However, surgical 
treatment provides effective clinical relief for selected patients with lumbar radicular pain due 
to disc herniation that fails to resolve with non-surgical management [35]. 
 
Strengths and limitations 
In the present study, we used strict inclusion criteria, validated questionnaires, and repeated 
assessments during the one-year follow-up. Modic changes and DD were rated with similar or 
higher reliability than that reported in some other studies [12, 36, 37]. The use of different 
MRI scanners and sequences, in the clinical practice, which provided the data for the present 
study, may have caused a slight but unwanted variation in the evaluation of the MRI findings. 
Modic type may differ between different MRI magnet strengths (0.2 T vs. 1.5 T) [38], but this 
potential problem was minimized, since 98% of the patients underwent 1.5 T (86%) or 1.0 T 
MRI (12%). 
 
Notably, recruitment from hospitals represents a selection of patients; we still suggest that 
Modic type I changes may delay pain recovery also in other patients with symptomatic disc 
herniation. Our sample was large enough to explore the impact of Modic changes on recovery, 
but it was too small to separately study the effects of Modic type I changes in the 
surgical and non-surgical groups. Published data support our adjustments for treatment, age, 
sex, smoking, and duration of sciatica in the analyses [18, 39]. Yet, additional factors might 
also have been relevant to adjust for. For example, data on emotional distress were not 
sampled, although other observations suggest that comorbid subjective health complaints 
influence the prognosis of symptomatic disc herniation [18]. Therefore, further studies are 
needed to confirm the present results. 
 
In conclusion, most patients with lumbar radicular pain treated surgically and non-surgically 
can expect a substantial reduction in back and leg pain during the first year. Patients with 
Modic type I changes may, however, have a slower decrease in McGill sensory pain score 
than other patients. Neither the type nor the size of Modic changes seems to influence on 
McGill sensory pain, VAS back pain, or VAS leg pain scores at one-year follow-up. 
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Figure legends 
 
Fig. 1 Overview of participant flow through the trial 
 
Fig. 2 Modic changes. Sagittal T2 weighted (a-c) and sagittal T1 weighted (d-f) MRI images 
showing Modic changes (arrows) in three different patients with lumbar radicular pain. (a, d) 
A 43-year-old woman with Modic type I changes inferior to the L5/S1 disc. (b, e) A 56-year-
old man with Modic type II changes superior (and inferior) to the L4/L5 disc. (c, f) A 45-year-
old woman with Modic type III changes superior to the L4/L5 disc 
 
Fig. 3 McGill sensory pain scores, grouped by Modic type, among patients treated 
surgically (A) and non-surgically (B). In both treatment groups combined, Modic type had a 
significant impact on McGill sensory pain score at 6 weeks (p = 0.007), when adjusting for 
treatment, age, sex, smoking status, duration of lumbar radicular pain, and disc degeneration; 
patients with Modic type I changes had higher McGill sensory pain scores at 6 weeks 
compared to patients with other Modic types (p = 0.003) or without Modic changes (p = 
0.018). Data are shown by mean ± standard error of the mean 
 
Fig. 4 VAS back pain scores, grouped by Modic type, among patients treated surgically 
(A) and non-surgically (B). In both treatment groups combined, Modic type had no 
significant impact on VAS back pain score at any time point, when adjusting for treatment, 
age, sex, smoking status, duration of lumbar radicular pain, and disc degeneration; VAS back 
pain scores did not differ significantly between Modic type groups at any time point. Data are 
shown by mean ± standard error of the mean 
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Table 1. Interobserver agreement on magnetic resonance imaging findings 
Finding Kappa* 95% confidence interval 
Modic type (none, type I, type II, or type III)  
L2/L3 inf to disc 0.66 0.52 to 0.80 
L3/L4 sup to disc 0.65 0.51 to 0.80 
L3/L4 inf to disc 0.63 0.51 to 0.75 
L4/L5 sup to disc 0.74 0.66 to 0.82 
L4/L5 inf to disc 0.64 0.56 to 0.73 
L5/S1 sup to disc 0.68 0.60 to 0.76 
L5/S1 inf to disc 0.58 0.49 to 0.66 
Modic craniocaudal (CC) size (five ordered categories)  
L2/L3 inf to disc 0.62 0.49 to 0.76 
L3/L4 sup to disc 0.61 0.48 to 0.73 
L3/L4 inf to disc 0.63 0.52 to 0.75 
L4/L5 sup to disc 0.77 0.70 to 0.83 
L4/L5 inf to disc 0.70 0.63 to 0.78 
L5/S1 sup to disc 0.72 0.66 to 0.78 
L5/S1 inf to disc 0.59 0.51 to 0.67 
Disc degeneration (DD) (four ordered categories)  
L2/L3 0.54 0.45 to 0.63 
L3/L4 0.67 0.60 to 0.73 
L4/L5 0.59 0.51 to 0.66 
L5/S1 0.55 0.47 to 0.63 
* Unweighted Kappa for Modic type, otherwise linearly weighted kappa; kappa values 
concern agreement between two observers evaluating Modic changes in 275 patients and 
DD in 250 patients, including the 243 patients participating in the present prospective 
study; kappa not given for levels where the evaluated finding had prevalence below 10% 
(mean of both observers). Agreement beyond chance was interpreted as very good (kappa 
value > 0.80), good (0.61–0.80), moderate (0.41–0.60), fair (0.21–0.40), or poor (≤0.20) 
(Sim and Wright 2005) [27].  
sup, superior; inf, inferior 
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Table 2. Baseline characteristics of total study population grouped by Modic type 
 
 All 
(n = 243) 
No Modic 
(n = 59) 
Modic I 
(n = 30) 
Modic II + 
III 
(n = 154) 
Age, years, mean (SD) 41.3 (10.5) 37.2 (11.8) 39.7 (8.5) 43.2 (9.8) 
Females, n (%) 114 (46.9) 31 (52.5) 19 (63.3) 64 (41.6) 
Smokers, n (%) 87 (35.8) 21 (35.6) 9 (30.0) 57 (37.0) 
High (i.e. university) 
educational level, n (%) 
104 (43.3) 23 (39.7) 14 (48.3) 67 (43.8) 
Duration of lumbar 
radicular pain, weeks, 
mean (SD) (range) 
17.3 (22.5) 
(0.3-208.0) 
12.4 (10.2) 
(0.3-44.0) 
21.1 (23.5) 
(0.7-104.0) 
18.5 (25.4) 
(0.3-208.0) 
McGill sensory, 
 mean (SD) 
0.5 (0.2) 0.5 (0.2) 0.5 (0.2) 0.5 (0.2) 
VAS back pain,  
mean (SD) 
4.0 (2.7) 4.4 (2.8) 3.6 (2.8) 3.9 (2.7) 
VAS leg pain,  
mean (SD) 
6.3 (2.8) 6.4 (2.8) 6.8 (2.8) 6.2 (2.8) 
ODI, mean (SD) 39.3 (19.4) 35.5 (18.7) 38.3 (16.0) 40.9 (20.1) 
SD, standard deviation; VAS, visual analogue scale, 0-10; ODI, Oswestry Disability 
Index, 0-100 
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Table 3. McGill sensory pain scores and VAS scores for LBP in the total study 
population (n = 243) over time, grouped by Modic type 
 
 McGill sensory pain score, mean 
(SD) 
VAS score for LBP, mean (SD) 
 Inclusion 6 weeks 6 months 12 months Inclusion 6 weeks 6 months 12 months 
No Modic 0.50 
(0.23) 
0.30 
(0.24) 
0.28 
(0.24) 
0.26 
(0.28) 
4.4 
(2.8) 
2.5 
(2.7) 
2.4 
(2.8) 
2.4 
(2.9) 
Modic  
type I  
0.55 
(0.21) 
0.45 
(0.28) 
0.31 
(0.25) 
0.30 
(0.30) 
3.6  
(2.8) 
3.1  
(3.0) 
3.1  
(2.8) 
2.5  
(3.1) 
Modic  
type II + III 
0.54 
(0.23) 
0.29 
(0.23) 
0.26 
(0.24) 
0.27 
(0.27) 
3.9  
(2.7) 
2.3  
(2.2) 
2.3  
(2.2) 
2.5  
(2.6) 
Total  0.53 
(0.23) 
0.31 
(0.24) 
0.27 
(0.24) 
0.27  
(0.27) 
4.0  
(2.7) 
2.5  
(2.4) 
2.4  
(2.5) 
2.5  
(2.8) 
VAS, visual analogue scale, 0-10; LBP, low back pain; SD, standard deviation 
Assessed for eligibility (n=299) 
Included (n=262)  
Allocated to follow-up (n=243)
Declined to participate (n=27)
Excluded (n=10)
Follow-up at 6 weeks (n=237)
Follow-up at 6 months (n=235)
Follow-up at 12 months (n=225)
Drop-out (n=6)
Drop-out (n=2)
Drop-out (n=10)
Missing of VAS, ODI, McGill (n=4), MRI (n=13) 
and blood samples (n=2) at baseline
Total drop-out  7.4%
 
  
Fig. 2 
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Brief Communications
Pain Intensity the First Year after Lumbar Disc Herniation Is
Associated with the A118G Polymorphism in the Opioid
Receptor Mu 1 Gene: Evidence of a Sex and Genotype
Interaction
Maria Belland Olsen,1 Line Melå Jacobsen,1 Elina Iordanova Schistad,2 Linda Margareth Pedersen,1,2 Lars Jørgen Rygh,3
Cecilie Røe,2 and Johannes Gjerstad1,4
1National Institute of Occupational Health, 0033 Oslo, Norway, 2Department of Physical Medicine and Rehabilitation, Oslo University Hospital, Ullevaal,
N-0424 Oslo, Norway, 3Department of Anesthesiology and Intensive Care, Haukeland University Hospital, N-5021 Bergen, Norway, and 4Department of
Molecular Biosciences, University of Oslo, N-0316 Oslo, Norway
Earlier studies have shown that the single nucleotide polymorphism (SNP)A118G (rs1799971) in the opioid receptormu1 (OPRM1) gene
may affect pain sensitivity. In the present study we investigated whether the A118G SNP could predict clinical outcome regarding
progression of pain intensity and disability in patients with low back pain and sciatica after lumbar disc herniation. Patients (n 258)
with lumbar disc herniation and sciatic pain, all European-Caucasian, were recruited from two hospitals in Norway. Pain and disability
were rated on a visual analog scale (VAS), by McGill Sensory Questionnaire and by Oswestry Disability Index (ODI) over a 12 months
period. The data revealed a significant interaction between sex and A118G genotype regarding the pain intensity during the 12 months
(VAS, p 0.002; McGill, p 0.021; ODI, p 0.205, repeated-measures ANOVA). We found that */G women had a slower recovery rate
than the */Gmen.Actually, the */Gwomenhad2.3 times asmuchpain as the */Gmen12months after thedisc herniation (VAS,p 0.043,
one-wayANOVA;p 0.035, TukeyHSD). In contrast, theA/AwomenandA/Amen seemed tohave almost exactly the same recovery rate.
The present data suggest that OPRM1G allele increases the pain intensity in women, but has a protective effect inmen the first year after
disc herniation.
Introduction
Many factors may contribute to the development of low back
pain and sciatica. These include age related changes, bodyweight,
smoking and occupational loading (Miranda et al., 2002; Younes
et al., 2006; Samartzis et al., 2011). Moreover, psychosocial as-
pects as well as genetic variability may affect the risk of long-term
low back pain and sciatica (Jacobsen et al., 2012).
One important genetic factor that may increase the risk of
persistent low back pain and sciatica is the single nucleotide poly-
morphism (SNP) A118G, rs1799971, in the opioid receptormu 1
(OPRM1) gene. This SNP leads to a substitution of asparagine
(Asn) to aspartic acid (Asp) at amino acid 40 and therefore re-
moval of a putative N-linked glycosylation site in the receptor
(Bergen et al., 1997; Bond et al., 1998). Recent data show that the
equivalent A112G SNP in the brain of mice leads to reduced
OPRM1 N-glycosylation and similarly that the human A118G
SNP causes decreased N-glycosylation and reduced stability of
the receptor in cell cultures (Huang et al., 2012).
Among individuals free of clinical pain it has been suggested
that 118G allele carriers, in particular men, have higher pressure
pain thresholds than118Acarriers (Fillingimetal., 2005).Carriersof
the 118Gallelemay alsohave lower cortical responses to experimen-
tal pain stimuli (Lo¨tsch et al., 2006). However, in contrast, the
women carrying the 118G allele seem to report more pain than the
women homozygous for the 118A the first 24 h after a cesarean
operation (Sia et al., 2008; Tan et al., 2009). In addition, evidence
exist that carriers of the OPRM1 118G allele may require higher
doses ofmorphine in the early postoperative period (Klepstad et al.,
2004; Chou et al., 2006; Hayashida et al., 2008).
Consistentwith these findings, the effect of the opioid agonists
have also been linked to sex and strain in animal experiments
(Baamonde et al., 1989; Vendruscolo et al., 2004). Moreover,
in mice, the OPRM1 G allele, depending on sex, may reduce
-opioid receptor expression in some brain regions (Wang et al.,
2012). In addition, earlier data suggest that the density of the
-opioid receptor may be different in the male and female hu-
man brain (Zubieta et al., 1999). Hence, we hypothesized that the
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OPRM1 A118G SNP may have different effects in men and
women as well. In the present study we demonstrate that the pain
after lumbar disc herniation is dependent on a sex and OPRM1
A118G genotype interaction.
Materials and Methods
Subjects. Patients with lumbar disc herniation and sciatic pain were re-
cruited fromOslo University Hospital, Ullevaal, Norway andHaukeland
University Hospital, Norway, during the period of 2007–2009 (Table 1).
Inclusion criteria were: age between 18 and 60 years, confirmed lumbar
disc herniation by magnetic resonance imaging (MRI) with correspond-
ing sciatic pain and positive Straight Leg Raising (SLR) test. Further
exclusion criteria were: lumbar spinal stenosis, previous surgery for her-
niated disc at the same level or fusion at any level in lumbar spine,
generalized musculoskeletal pain, inflammatory rheumatic disease, dia-
betic polyneuropathy, cardiovascular disease (NYHA III and IV), cancer,
psychiatric disease, neurological disease, alcohol or drug abuse, comple-
tion of another surgery within 1month, pregnancy, nondetectable geno-
type, non-European-Caucasian ethnicity or poorNorwegian language. A
total of 258 patients were included in the present study. However, at
inclusion, 6 patients changed their mind and did not want to participate,
which gave us data from 252 patients. In addition, 21 patients (8%)
dropped out during the follow-up.
All participants received written information and signed an informed
consent form. The study was approved by theNorwegian Regional Com-
mittee for Medical Research Ethics and the Norwegian Social Science
Data Services.
Clinical procedure. After inclusion, the newly diagnosed patients had a
follow-up at 6 weeks, 6 months and 12 months. Conservative treatment
was received by 42% and surgical treatment received by 58%. At the time
of inclusion, all patients underwent a standardized clinical examination
including assessment of sensory and motor function and tendon reflexes
of the lower limbs as well as an MRI scan. At 6 weeks follow-up, the
clinical examination was repeated, while at 6 months follow-up, patients
reported their back condition by a telephone interview and answered
questionnaires by mail. At 12 months follow-up, patients underwent the
same examination as by inclusion, and if their pain was persistent, an
MRI scan was repeated. The sampling of the clinical data was completed
before the genotyping of the patients was performed.
Clinical measures. All patients were asked to rate their pain intensity in
activity during the last week on a 10 cm visual analog scale (VAS) with
endpoints “no pain” and “worst possible pain.” The validatedNorwegian
version of the McGill questionnaire was used to measure the sensory
components of the pain experience (Strand and Wisnes, 1991). The val-
idatedNorwegian version of theOswestryDisability Index (ODI) (Grotle
et al., 2003) was used to assess problems with physical function related to
low back pain.
Genotyping. Blood samples were drawn and genomic DNA was
extracted from whole blood cells using FlexiGene DNA isolation kit
(Qiagen). SNP genotyping was performed using predesigned TaqMan
SNP genotyping assays (Applied Biosystems). Approximately 10 ng of
genomicDNAwas amplified in a 5l reactionmixture in a 384-well plate
containing 1 TaqMan genotyping master mix (Applied Biosystems)
and 1 assay mix, the latter containing the respective primers and
probes. The probes were labeled with the reporter dye FAM or VIC to
distinguish between the two alleles. After initial denaturation and en-
zyme activation at 95°C for 10min, the reactionmixture was subjected to
60 cycles of 95°C for 15 s and 60°C for 1 min. The reactions were per-
formed on an ABI 7900HT sequence detection system. Negative controls
containing water instead of DNA were included in every run. Genotypes
were determined using the SDS 2.2 software (Applied Biosystems). Ap-
proximately 10% of the samples were re-genotyped and the concordance
rate was 100%.
Data evaluation and statistics. The data are shown as means  SEM.
VAS activity score, McGill sensory score and ODI measurements over
time were compared regarding sex and OPRM1 genotypes with the
groups; women */G, men */G, women AA and men AA by repeated
measures ANOVA, within-subjects effect. When sphericity assumption
was notmet, a Greenhouse-Geiser correction was applied. Separate anal-
yses were performed to check for potential effects of covariates age,
smoking status and treatment. Covariates with p 0.1 were kept in the
final model (Table 2). Finally, VAS activity score, McGill sensory score
and ODI score at 12 months were examined regarding the four sex/
genotype groups by a one-way ANOVA and Tukey honestly significant
difference (HSD) post hoc comparison. Statistical analyses were per-
formed using the statistical package PASW statistics 18 (SPSS). A p value
0.05 was chosen as the level of statistical significance.
Results
The present material of the 252 patients consisted of 94 homozy-
gous A/A, 20 heterozygous A/G and 3 homozygous G/G among
the females, and 94 homozygous A/A, 40 heterozygous A/G and 1
homozygous GG among the males. The allele frequency of the G
allele was therefore 13%, which is in accordance with previous
reports from Caucasian populations (Klepstad et al., 2004).
As expected, we observed a clear decrease in pain and disabil-
ity over time the first year after the disc herniation (VAS p 
0.000, McGill p  0.000, ODI p  0.000, repeated-measures
ANOVA). From inclusion to 6 weeks, a distinct reduction in pain
was observed, whereas a less pronounced reduction in pain in-
tensity was observed from 6 weeks to 6 and 12 months.
Interestingly, however, our data showed that the decrease in
pain and disability, i.e., the recovery after disc herniation, may be
affected by both sex and the OPRM1 A118G SNP. A significant
interaction between sex and genotype regarding the pain experi-
ence over timewere observed (VAS, p 0.002;McGill, p 0.021;
ODI, p  0.205, repeated-measures ANOVA, women */G, men
*/G, women A/A and men A/A, including covariates smoke,
treatment and age with p 0.1).
The genotype */G seemed to be associated with more pain in
women, but to protect the men from pain after lumbar disc her-
niation (Fig. 1).Wild-type A/Awomen andmen reported similar
pain ratings. Hence, the women carrying */G alleles appeared to
have a slower recovery than the */G men.
The analysis of main outcome, i.e., pain and disability at 12
months, showed a significant association between sex and geno-
type regarding the pain experience (VAS, p 0.043; McGill, p
Table 1. Characteristics of patients grouped by sex and OPRM1 A118G genotype
Women */G
(n 23)
Men */G
(n 41)
Women A/A
(n 94)
Men A/A
(n 94)
Mean age (min-max) 43 (26 –58) 41 (24 –57) 41 (18 –59) 41 (19 – 60)
Current smoker, yes/no (%) 9/14 (39/61) 13/28 (32/68) 31/63 (33/67) 39/55 (41/59)
Treatment, conservative/
surgery (%)
9/14 (39/61) 18/23 (44/56) 44/50 (47/53) 35/59 (37/63)
Min, minimum; max, maximum.
Table 2. Significance of covariates
Outcome measure
Repeated-measures ANOVA
Covariates
Within-subjects
effects, p values
Between-subjects
effects, p values
Included in final
model, yes/no
VAS Age 0.844 0.002 Yes
Smoking 0.697 0.924 No
Treatment 0.000 0.250 Yes
McGill Age 0.428 0.019 Yes
Smoking 0.343 0.086 Yes
Treatment 0.000 0.003 Yes
ODI Age 0.417 0.003 Yes
Smoking 0.070 0.150 Yes
Treatment 0.000 0.150 Yes
The tablegives anoverviewof theassociationbetween covariates and the threeoutcomemeasures: VAS,McGill, and
ODI. Covariates with a p value 0.1 were included in the final model.
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0.103; ODI, p 0.057, one-way ANOVA, women */G, men */G,
women A/A andmen AA).Mean SEM values at 12months are
listed in Table 3.
The post hoc comparison further confirmed that the */G
women hadmore pain than the */Gmen (VAS, p 0.035, Tukey
HSD). However, the wild-type men and women seemed to have
the same pain level (VAS, p  0.993, Tukey HSD). The women
carrying the 118G allele had, 12 months after the disc herniation,
2.3, 1.8 and 2.0 times higher VAS,McGill, andODI scores respec-
tively than the men with the same genotype.
Discussion
For the first time we demonstrate an interaction between sex and
OPRM1 A118G genotype regarding recovery of low back pain
and sciatica. Clearly, women with the */G genotype reported
more pain than the */G men 12 months after the disc herniation.
However, women and men with homozygote A/A alleles had
almost exactly the same recovery rate regarding the pain inten-
sity. Hence, our data indicated that the OPRM1 118G allele af-
fected the clinical outcome after a disc herniation and that the */G
women had a slower recovery than the */G men.
Our study support the earlier observation that female sciatic
patients may have a slower recovery and a poorer one-year out-
come thanmale sciatic patients (Peul et al., 2008). However, here
we have extended these findings and demonstrated that the pain
also is related to a sex-specific genetic factor. As presented in this
study, women carrying the 118G allele had a mean VAS pain
score 2.3 times higher than men with the same genotype 12
months after the lumbar disc herniation. Earlier data show that
women carrying the 118G allele may have increased basal level of
cortisol (Bart et al., 2006), consistent with a higher report of pain.
Together these findings suggest that the high pain intensity in
women compared with men in the low back pain and sciatic
patients 12 months after the lumbar disc herniation may be re-
lated to the 118G substitution.
The present data are consistent with the observations of more
pain in women carrying the 118G allele 24 h after a cesarean
operation (Sia et al., 2008; Tan et al., 2009) and with carriers of
the 118G allele, in particular males, having higher pressure pain
thresholds (Fillingim et al., 2005). Interestingly, Fillingim and
colleagues reported that */G women might be more sensitive to
heat pain than A/A women and that the */G men might be less
sensitive to heat pain than the A/A men. Moreover, sex-specific
effects regarding the A118G SNP and reward effects of stimulants
have been found. For example, women carrying the 118G allele
have reported attenuated reward effects of nicotine (Ray et al.,
2006). Also, female rats, homozygote for the 112G allele, an
equivalent to the 118G allele in humans, have shown diminished
reward properties of morphine (Mague et al., 2009).
At the molecular level, consistent with our observations of
more pain in */G women, a 1.5–2.5-fold reduced mRNA ex-
pression of the OPRM1 has been found in human brain tissues
of 118G carriers and a further tenfold reduction in protein
levels has been found in cell cultures (Zhang et al., 2005).
However, the molecular phenotype of the OPRM1 A118G
seems to be region specific. For example, data from humans
obtained by harvesting brain tissue postmortem have demon-
strated that 118G allele carriers have a decreased receptor sig-
naling efficacy in response to DAMGO in the secondary
somatosensory cortex (Oertel et al., 2009). Moreover, posi-
tron emission tomography (PET) data based on the OPRM1
ligand tracer [ 11C]carfentanil have suggested that smokers
carrying the 118G allele may have lower levels of receptor
binding potential in the amygdala, thalamus, and anterior cin-
gulate cortex (Ray et al., 2011).
The Asn to Asp amino acid exchange results in reduced
OPRM1 N-glycosylation (Huang et al., 2012). N-glycosylation,
which has been suggested to be region-specific (Huang et al.,
2008), plays a part in many cellular processes like receptor fold-
ing, sorting, expression, and ligand binding. As the level and type
of N-glycosylation is found to differ in men and women
(Knezevic´ et al., 2009; Stanta et al., 2010; Ding et al., 2011), this
mechanism has been proposed as a possible explanation for the
region- and sex-specific differences observed for the OPRM1
A112G expression in themouse brain (Wang et al., 2012). Hence,
and in accordance with the data in the present study, it is tempt-
ing to speculate that lack of N-glycosylation, as a consequence of
the amino acid exchange in the -opioid receptor, also may give
sex-specific effects with regards to pain sensitivity in patients.
Figure 1. The time course for outcome measures grouped by sex and A118G genotypes
following disc herniation. A, VAS activity score ( p 0.002, rm ANOVA; p 0.043 one-way
ANOVA at 12 months). B, McGill sensory score ( p 0.021, rm ANOVA; p 0.103, one-way
ANOVA at 12 months). C, ODI score ( p 0.205, rm ANOVA; p 0.057, one-way ANOVA at 12
months). Data are given as means SEM.
Table 3. Pain and disability ratings at 12 months
VAS activity McGill sensory ODI
Women */G 3.51 0.58 0.31 0.06 19.92 2.87
Men */G 1.56 0.41 0.17 0.04 9.89 1.88
Women A/A 2.42 0.27 0.28 0.03 14.66 1.47
Men A/A 2.67 0.30 0.29 0.03 15.00 1.59
The table shows the 12 month VAS, McGill, and ODI scorings for the patients grouped by sex and A118G genotype.
Mean SEM values are shown. *G or A allele.
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In conclusion, the present data demonstrate that the OPRM1
118G allele is associated with increased pain intensity in women,
but reduced pain intensity in men the first year after a disc her-
niation. This finding strongly support the hypothesis that the
OPRM1 118G allele may influence the endogenous pain modu-
latory system differently depending on sex, which also might be
relevant for the understanding of the mechanisms underlying
development of persistent low back pain and sciatica.
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